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Summary 
 
Ligand-activated signal transduction is a process critical to cell survival and function as it 
serves as a means of communication between the cells and their environment. Endocytosis is 
generally thought to down-regulate incoming signals by reducing the surface availability of 
receptors. However, increasing evidence in many systems suggests a notion which is referred 
to as the „signalling endosome‟ hypothesis - that endocytosis can also actively contribute to 
signalling apart from clearance of activated receptors and thereby attenuation of signalling. 
The functional aspect of signalling endosomes has been well-characterized in several 
pathways including RTK and TGF-β signalling. There are, however, various other signalling 
pathways where the active mechanism of endocytotic regulation is yet to be understood.  
In this study, we probe this aspect in the cytokine signalling system, where the receptors are 
known to internalize but the significance of such internalization and precise mechanism is 
unclear. My thesis aims to elucidate the function and molecular details of internalization of 
cytokine receptor using interleukin-4 receptor (IL-4R) signalling as a model. IL-4 and IL-13 
ligands can induce assembly of three distinct complexes: IL4 induced IL-4Rα – IL-2Rγ (type 
I), IL-4 induced IL-4Rα – IL-13Rα1 (type II) or the IL-13 induced IL-13Rα1-IL-4Rα (type 
II). The formation of any of these complexes triggers signalling through the JAK/STAT 
pathway. However, models of how the oligomerization of the transmembrane receptors and 
activation takes place are very diverse and lack a clear molecular and biophysical 
understanding of the underlying receptor dynamics.  
Previous results of the lab had shown that the affinities between subunits are low, precluding 
complex formation at the plasma membrane at physiological concentrations. In addition, IL-
4R subunits localize in to endosomal structures adjacent to the plasma membrane. It had 
already been shown that the shared IL-4R subunit IL-2Rγ is internalized by a specific, actin 
dependent, Rac1/Pak1 regulated endocytosis route in the IL-2 context. We could show that 
pharmacological suppression of this endocytosis pathway also prevented IL-4 induced 
JAK/STAT signalling, placing endocytosis upstream of signalling. 
Here I show using immuno-EM techniques that these endosomal structures are multivesicular 
bodies. Importantly, I could show that receptor subunits are highly enriched in the limiting 
membrane of these endosomes relative to the adjacent plasma membrane. Using quantitative 
loading assays I could furthermore demonstrate that this enrichment is achieved by 
constitutive internalization of receptors from the cell surface into cortical endosomes. The 
trafficking kinetics of the receptor subunits is independent of ligand occupancy. 
Pharmacological inhibition shows that receptors and ligand traffic via the previously 
identified Rac1/Pak1 pathway. Finally, Vav2 was identified as a candidate Guanine 
Exchange Factor (GEF) that may regulate Rac1 activity and thereby control the actin 
polymerization cascade driving IL-4R endocytosis. Immunoprecipitations showed that Vav2 
interacts both with the cytoplasmic tail region of the receptors and the receptor associated 
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kinase JAK3. Vav2 may thus couple the receptor/JAK complexes to the Rac1/Pak1 mediated 
endocytosis route. 
Taken together, our results suggests that stable „signalling endosomes‟ adjacent to the plasma 
membrane act as enrichment centres, where ligand and receptor concentrations are locally 
increased by constitutive trafficking. The confined environment of the endosome then 
compensates for the weak affinities between the ligand and receptor and facilitates ligand-
mediated receptor dimerization. Importantly, overexpression of both type II IL-4R subunits 
renders signal transduction resistant to endocytosis inhibition, strongly suggesting that the 
critical factor effecting signalling is sufficient concentration, which the endosomes facilitate 
achieving. The endosomes are thus dispensable as signalling scaffolds when the receptors are 
in sufficient concentration, where activated receptors could interact with downstream 
pathway components.  
Endocytosis thus provides a crucial means for the signalling process to overcome the 
thermodynamic hurdles for receptor oligomerization. In conclusion, our data propose a novel, 
purely thermodynamic role of endosomes in regulating cytokine receptor signalling not seen 
in any other signalling pathway.  
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Chapter 1 
 
 
 
 
 
 
 
Introduction 
 
Cells must sense their environment and respond to stimuli in order to maintain homeostasis 
and to coordinate cellular events depending on their context. All cells have a plasma 
membrane as the first barrier to the extracellular milieu. Among the many mechanisms to 
sense the external signals, the most diverse are the ligand-based signal process. In this 
chemical-based signaling, a secreted compound - typically a small protein or peptide - binds 
to its specific trans-membrane receptor on the extra cellular side, thereby activating it. 
Therefore, the receptors at the plasma membrane are usually the first sensors of signals. 
However, “sensing” is a broad term and further in this thesis, a distinction between binding of 
receptors and subsequent activation will be made. When discussing the mechanistic basis of 
signal transduction, it is important that the subtle difference between binding and activation is 
kept in mind. 
 
1.1 Signaling from plasma membrane 
 
The occupation of receptors by ligand must be transduced across the plasma membrane. This 
happens mainly through two distinct mechanisms. The first mechanism is through a 
conformational change upon ligand binding, which affects protein interactions on the 
intracellular side. G protein coupled receptors (GPCRs) are a prime example of this [1]. The 
primary architecture of these receptors is seven transmembrane domains linked by 
extracellular and intracellular loops. Upon binding of a ligand, conformational changes allow 
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GPCRs to act as a guanine exchange factor (GEF) by bringing together the intracellular 
loops. This sets off a intracellular signal transduction cascade through the activation of 
heterotrimeric G-proteins, which often eventually results in transcriptional modulation. The 
GPCRs have a wide variety of ligands ranging from small molecules to large proteins [2]. 
Chief examples of GPCR activating molecules are neurotransmitters, pheromones, hormones 
etc.  
The second mechanism involves receptor oligomerization upon binding to ligand. The 
general model is that the inactive receptor monomers are in equilibrium with the dimeric 
receptors in a way that the equilibrium greatly favors the monomeric forms. Upon binding of 
ligands, the equilibrium is shifted to “active” homo dimers or hetero dimers. This 
dimerization brings together active enzymatic molecules into close proximity, resulting in 
reactions which give rise to downstream signaling [3]. Using either of these general 
mechanisms, the signal sensed at the extracellular side is transmitted across the plasma 
membrane to the cytoplasm. The precise mechanism of how the oligomerization may be 
facilitated, or the equilibrium shifted upon ligand binding depend on many finer details of the 
system and may vary substantially. Cytokine receptor signaling [4, 5], which is the receptor 
system investigated in this thesis, belongs to the second group of receptors which depend on 
oligomerization to transmit the activation across the plasma membrane. The details of the 
oligomerization in this system are described later in this thesis.  
 
 
Figure 1.1: Signaling from the plasma membrane. (A) Ligand binding to GPCR triggers 
conformational changes in the receptor. These changes are translated into dissociation of associated 
signal transduction molecules (heterotrimeric G proteins) (B) Ligand binding to the receptor chain 
causes a recruitment of a second receptor. This brings the receptor subunit in close proximity, which 
allows cross-phosphorylation of tyrosine or serine/threonine residues kinases. This activity can either 
be provided by the receptor itself or by associated kinases. Phosphorylation typically provides 
docking sites for downstream signaling molecules.  
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1.2 Receptor endocytosis 
 
It was also observed that, upon activation, many receptors enter the endosomal trafficking 
system [6]. The endosomal system is a dynamic system of internalization of membrane 
compartments, which undergo membrane remodeling and extensive directed transport. The 
typical cascade of events that follow any endocytosis is trafficking and fusion of the 
endocytic carriers to early endosomes and their subsequent maturation into recycling 
endosomes, late endosomes, and lysosomes, as represented in Figure 1.2. These 
compartments are distinct in their lipid and protein composition. This facilitates recruitment 
of specific proteins to them. All these intracellular compartments are highly dynamic and 
exchange cargo and lipids with other membrane compartments. Each endosomal 
compartment is also characterized by a particular set of associated Rab GTPases which serve 
to recruit additional molecules that provide its specific, cell biological functions [7].  
 
Figure 1.2: Membrane compartments in Trafficking. Cargo is internalized at the plasma membrane 
by different pathways. Endocytosed cargo proteins are sorted in early endosomes, which may recycle 
back to the plasma membrane or are targeted to late endosomes and lysosomes. Late endosomes are 
characterized by the presence of intra-lumenal vesicles and are known as multivesicular bodies. 
Cargo molecules may also undergo retrograde transport from early endosomes to reach the 
endoplasmic reticulum via the Golgi. Modified from [8] 
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1.3 Signaling and endocytosis 
 
The process of receptor endocytosis was classically thought to be only meant for clearing the 
activated receptor population from the plasma membrane to attenuate signaling [9]. 
Accordingly, receptor endocytosis was generally thought to be triggered by pathway 
activation. However, this view has been evolving with findings that in many cases, 
endocytosis of receptors and signaling may be tightly coupled and internalized membrane 
compartments may be sites of signaling [9, 10]. This is not surprising as the receptors have to 
be expressed at the plasma membrane to sense extracellular cues, and the signaling molecules 
must be carried to the intracellular milieu. Therefore, it is foreseeable that the membrane 
trafficking and signaling components interact strongly to manifest signaling events.  
Ligand-induced endocytosis is typical of signaling receptors like receptor tyrosine kinases 
(RTKs) [11-14]. In the case of RTKs, one of the important roles of endocytosis is to remove 
activated receptors from the plasma membrane and funnel them towards degradation. This 
particular pathway leading to degradation achieves a negative-feedback loop resulting in 
inhibition of signaling and modulates the response of the cell to an external signal. The 
pathway of endosomal maturation leading to degradation involves the formation of multi 
vesicular bodies (MVBs) which are characterized by the presence of intra-lumenal vesicles. 
The formation of the MVBs depends on the Endosomal Sorting Complex Required for 
Transport (ESCRT) machinery [15, 16]. Internalization of vesicles into the MVB lumen cut 
off any cargo that is associated with the vesicles from the cytoplasm of the cell. However, 
receptor endocytosis does not necessarily turn off the signaling process initiated by the ligand 
binding. Internalized receptors rather continue or in many cases begin active signaling after 
activation from the surface of the endosomes. This link between endocytosis and signaling 
has been established to be biologically significant for at least some pathways. Internalized 
receptors in the endosomes can give rise to spatial and temporal differentiation of signaling as 
has been exemplified by some specific receptor systems like Nerve Growth Factors (NGF) 
[17], Epidermal growth factor (EGF) [18] and transforming growth factor-beta (TGFβ) [19].  
 
1.4 Spatio-temporal regulation of signaling through endosomes 
 
An extreme case of role of endocytosis in spatial regulation is demonstrated by studies on 
NGF [20]. Growth factors released from tissues, which bind to the NGF receptor TrkA, a 
member of the RTK family, must carry out signaling events sustainable across the long 
distance from the axon of a neuron to the cell soma. This is facilitated by the internalization 
of activated TrkA receptors into „signaling endosomes‟, which are actively transported from 
the axon to the soma through the retrograde pathway [21]. This results in the signaling 
components being present at an effective proximity to carry out robust and sustained 
signaling, even if the receptors sensed the ligands at an otherwise ineffective distance. 
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Figure 1.3: Spatial regulation in signaling through endosomes. NGF binds to its receptor TrkA at 
the axonal growth cones, far away from the cell soma. Diffusion kinetics will be too slow to allow 
signaling molecules to reach the cell soma resulting in a response. The activated receptors are 
instead internalized into endosomes, which are actively transported through the axon back to the cell 
soma, thus overcoming the long distance resulting in effective signaling. The receptors are also 
replenished in the axon through active forward transport of Rab11 positive recycling endosomes 
Modified from [22] 
Temporal regulation by endosomes is chiefly achieved by tuning of the kinetics of the events 
leading to internalization and further recruitment of downstream proteins. Different members 
of the GPCR family differ in their kinetics of internalization upon activation by agonists. In 
general, activation results in phosphorylation of GPCRs and binding to β-arrestins, resulting 
in clathrin dependent receptor internalization. β-arrestins provide a scaffolding function for 
intracellular assembly of further downstream signaling complexes, which includes the 
Mitogen-activated protein kinases (MAPK) and c-Jun N-terminal kinase 3 (JNK3) pathways. 
Dissociation of β-arrestins results in recycling via Rab4 and Rab11 dependent mechanisms or 
degradation in lysosomes. The kinetics of different GPCRs is controlled by the affinity of β-
arrestins for different GPCRs and this leads to differential lifetimes of the receptors in the 
endosomes. This results in different degrees of signaling by different GPCRs from 
endosomes [23-25].  
EGFR signaling provides an example of how subcellular spatial sorting through endocytosis 
leads to coordinate temporal regulation of the signaling output [26]. EGF receptors signal 
through phosphatidylinositide 3-kinases (PI3K) from the plasma membrane and via the 
MAPK pathway from early and late endosomes. Receptors are activated upon ligand binding 
at the plasma membrane. Activated receptors at the plasma membrane signal through PI3K 
pathway, but this signal is abrogated following receptor internalization [27, 28]. Instead, 
binding of the scaffold protein MP1-p14 to the receptor, which only happens at the 
endosome, and then drives extracellular signal-regulated kinases (ERK) mediated signaling. 
Thus, activation of the EGFR gives rise to a temporally coordinated sequence of signaling 
events.  
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Figure 1.4: Endosomes and signaling. (A) Downregulation of signals through the degradation of 
receptor complexes. Receptors trafficked to multilamellar endosomes fuse with lysosomes, where 
receptors are degraded. (B) Receptor Tyrosine kinsases (RTKs) and GPCR are an example of 
downstream signaling being maintained by early endosomes. (C) Downstream signaling of 
transforming growth factor-β-receptors (TGFβR) is only generated on endosomes. The endosomal 
protein SMAD anchor for receptor activation (SARA) brings the activated receptor and the SMAD 
transcription factor into contact which results in downstream signaling. Modified from [29]. 
While EGFR signaling at least partially occurs from the membrane, in the case of TGFβ, the 
activation by ligands takes place at the plasma membrane, but signaling takes place only after 
receptor internalization. The activated TGFβ receptor localizes into Rab5-positive early 
endosomes. On these endosomes, SMAD anchor for receptor activation (SARA) is also 
recruited. Coordination of SARA and TGFβ is necessary to phosphorylate SMAD2 and 
achieve propagation of signal [30, 31]. This exemplifies the role of endosomes in proper 
signaling where the endosome, by virtue of its specific recruitment of different components, 
bring together a functional unit to result in active signaling, even if the receptor activation 
took place in the plasma membrane.  
Various other studies also highlight the significance of endocytosis in a range of critical 
processes of biological systems. Examples can be found in establishment of morphogen 
gradient [32], EGFR, symmetric distribution of signaling components following cell division 
[33]etc. Therefore, it appears that endocytosis has not only evolved as a mechanism of 
receptor clearance, but has strongly co-evolved with various signaling mechanisms to fulfill 
certain functional requirements.  
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1.5 Pathways of receptor endocytosis 
 
Many of the receptor uptake pathways known so far are ligand-triggered, Clathrin-dependent 
pathways. Typically, in this pathway, receptor phosphorylation leads to recruitment of 
ubiquitin ligases [34]. Ubiquitination of receptor triggers recruitment of clathrin adaptors and 
then endocytosis via Clathrin-coated pits. However, receptors are also internalized by other 
mechanisms. Many receptors including GPCRs, RTKs, WNT, NOTCH, and TGFβR can take 
multiple portals of entry into the cell [10]. For example in EGFR and TGFβR signaling, 
internalization of receptors via Caveolin-mediated pathway leads to their degradation thus, 
limiting signaling. However, there are several other pathways that are not marked by the 
presence of coat proteins, for example GPI-AP-enriched early endosomal compartments 
(GEECs) and Clathrin independent carriers (CLICs) [35]. A second mode of coat 
independent mechanisms seems to be utilizing the actin cortex and its regulatory proteins. In 
these pathways, the actin machinery is required for providing structural support for 
trafficking intermediates as well to generate forces for membrane deformation. Regulation of 
actin in most of the processes in the cell occurs through a large number of signaling cascades. 
This involves the members of the Rho family of small GTPases- rhoA, cdc42 and rac1 and 
their activators (GEFs), as well as their protein kinase effectors [36]. These molecules may 
directly interact with actin or regulate it through other actin nucleating/branching proteins. In 
general, they act as coupling factors that converge to regulate the dynamics and organization 
of the actin cytoskeleton and have been implicated in regulation of endocytosis by coupling 
cargo proteins to cytoskeletal changes and signaling events. 
 
1.6 Endocytosis in cytokine signaling 
 
Cytokines are ligands belonging to a diverse group of soluble proteins and peptides, which 
act as signaling molecules with functions in immunomodulation. These immunomodulating 
agents generally refer to interleukins and interferons. Interleukins are produced by a wide 
variety of cells. The receptors for these ligands fall under the cytokine receptor family [5]. 
The principle behind their transmembrane signaling is generally thought to be ligand induced 
oligomerization.  
A unique type of signaling pathway that is clathrin independent has been reported for certain 
cytokine receptors. Previous studies have established that IL-2R, the first interleukin receptor 
to be characterized in this respect, internalizes through a clathrin independent mechanism 
[37-41].  
The internalization in this case occurs through a Rac1/Pak1-mediated pathway and is also 
thought to involve ordered domain forming lipid components (“rafts”) [39]. This pathway is a 
general actin polymerization regulatory pathway utilized for a broad range of processes. 
Internalization of cytokine receptor was thought to terminate signaling [42-45]. However, this 
is contradicted by studies describing positive effects of endocytosis on signaling. For 
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example, in IL-7R and in Drosophila Domeless receptors, endocytosis is implicated in 
cytokine receptor activation [44, 46]. But the mechanistic link between endocytosis and 
signaling components is unknown.  
Using the IL-4 receptor system, our labs have characterized the oligomerization dynamics of 
the receptors in vivo ([47] and unpublished data). It was observed that the expression of the 
receptor components resulted in localization of the receptors into endosome like structures, 
suggesting that they undergo endocytosis, as has been previously reported for IL-2R and IL-
7R systems. Furthermore, measurements of the dissociation constants using fluorescence 
correlation spectroscopy revealed that the lateral affinities between subunits were very low, 
such that receptor complexes would not be detectable without overexpression to higher 
concentrations. Therefore, the receptor complex formation resulting in active signaling may 
be thermodynamically unfavorable due to insufficient concentrations of the receptors at 
physiological conditions.  
 
 
Figure 1.5:  Major endocytic pathways with focus on clathrin-independent pathways and their 
cargoes. Apart from the canonical clathrin mediated pathway many pathways are dependent on actin 
machinery. These pathways are characterized by specific cargo proteins that use them for their 
internalization. For e.g. RTKs are known to be internalized by clathrin mediated endocytosis, whereas 
cholera toxin is a marker for CLIC/GEEK pathway. IL-2R is known to be internalized by a clathrin 
independent, actin mediated pathway. Figure modified from [48]. 
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The Rac1/Pak pathway has been implicated in endocytosis of IL-2R [41]. Therefore, our 
working hypothesis was that IL-4R was also internalized via Rac1/Pak mediated pathway. 
Previous work in the lab had also shown that signaling by IL-4R was dependent on Rac1/Pak 
pathway activating actin polymerization machinery, suggesting a positive role of 
internalization of receptors into endosomes in active signaling, given that inhibition of 
Rac1/Pak also blocks endocytosis.  
The three major facts observed in the lab – consistent observation of receptor components in 
endosomes, low affinity of the receptors, and requirement of internalization for active 
signaling suggests that endosomes play a very significant role in signaling.  
Therefore, the work in this thesis is aimed at understanding the role of endosomes in IL-4 
receptor signaling mainly at two complementary levels: ultrastructural and molecular 
characterization of the signalling endosomes and the dynamics of receptor trafficking. Based 
on the previous observations, we hypothesized IL-4R systems use endosomes to fulfill a 
function relating low affinity of the receptors and formation of active complexes. Since both 
endosome formation and signaling are highly dynamic processes, I seek to employ a range of 
static and dynamic analyses to elucidate their interplay. Further, I aim to confirm the role of 
Rac1/Pak-mediated actin regulation in the endocytic pathway used by IL-4R. This pathway is 
known to be involved in lamellipodia and filopodia formation as well and it is not yet clear 
how general actin polymerization machinery could be coupled to the internalization of a 
specific receptor system. I address this question by using a candidate-based approach to find 
the specific molecular link between actin modulation and IL-4R internalization. Thus, the 
aims of this study can be summarized as follows: 
  
 Aim1: What is the molecular nature of the compartments containing cytokine 
receptors? How are they organized at the morphological and ultra-structural 
level? 
      
 Aim2: What are the dynamics of receptor trafficking between the plasma 
membrane and the internalized compartments? Are they dependent on ligand 
activation or are internalized constitutively? What functionality do they serve?  
 
 Aim3: What molecules regulate the process of receptor internalization at the 
plasma membrane? What links the receptors to the actin polymerization 
machinery? 
 
To achieve these aims I used a variety of cell biological, biophysical, biochemical, and 
imaging approaches.  
In Chapter 3, I will describe the cytokine system and characterization of the endosomes at 
molecular and ultrastructural level using immunocytochemistry and electron microscopy.  
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Chapter 4 focuses on a biophysical analysis of interleukin receptor endocytosis to quantify 
trafficking kinetics using live cell imaging.  
Chapter 5 focuses on the identification of the upstream regulator molecule that links IL-4R 
subunits to the actin dependent endocytic machinery using biochemistry and a candidate-
based approach. 
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Chapter 2 
 
 
 
 
 
 
 
Materials and methods 
 
2.1 Materials 
 
All chemicals, unless otherwise mentioned, were purchased from Roth or Sigma. All 
restriction enzymes were purchased from New England Biolabs (NEB) or Fermentas. The 
manufacturer of other reagents is indicated in the respective section.  
 
2.1.1 Constructs  
 
pJAK3-TagRFP was created form pJAK3-eGFP by removing the eGFP sequence via 
AgeI/NotI, followed by insertion of TagRFP. pNHis-IL-2Rγ -N2 plasmid was derived from 
pNHis-IL-2Rγ -eGFP-N2 by NotI/SmaI digest followed by Klenow fill-in and re-ligation. 
pCMV-STAT6 was generated by replacing the eGFP ORF in pEGFP-N1 with the ORF of 
human STAT6 excised from the Flexi clone F1KB4980 (Kazusa DNA Res. Inst., Kisarazu, 
Japan.).  pCMV-Vav2 was generated by replacing the ORF in pEGFP-stat6-C1 with the ORF 
of human Vav2 excised from the Flexi clone F1KB4980 (Kazusa DNA Res. Inst., 
Kisarazu,japan). Truncated mutants of IL-2Rγ – Δ25 to Δ40 were a kind gift from Dr. Sigrun 
Hofmann (Department of Pediatrics, University Hospital Carl Gustav Carus). 
For all PCR amplification, native Pfu polymerase was used. PCR products were cloned in 
PJet vector.  For digestion all the enzyme were used from New England Biolabs. For ligation, 
Fast link DNA ligation kit from EPICENTRE Biotechnologies was used. Mutagenesis was 
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achieved by QuickChange lightning single or multi mutagenesis kits (Agilent Technologies). 
New clones were evaluated by restriction digestion. Clones were sequenced at MPI-CBG 
DNA sequencing facility.  
 
2.1.2 Cloning strategy 
 
Plasmid Template 
for PCR 
Forward 
primer 
Reverse 
primer  
PJet 
clone  
Insert digested with 
enzymes 
Vector digested with 
     Insert Enzyme Vector  Enzyme 
pCMV 
Vav2-
Nterm-
HA 
pCMV-
Vav2  
cmv_fwd  linker 
rev SpeI 
pJet 
Nterm 
pJet Nterm NotI/SpeI pCMV-Vav2 NotI/RsrII 
            pCMV-Jak3-
1xFK 
SpeI/RsrII 
pCMV-
Vav2 
∆SH2SH
3-HA 
pCMV-
Vav2  
cmv_fwd  SH3_1 
rev SpeI 
pJet 
∆SH2S
H3-HA 
pJet 
∆SH2SH3   
NotI/SpeI pCMV-Vav2 NotI/RsrII 
            pCMV-Jak3-
1xFK 
SpeI/RsrII 
pmRFP-
Vav2SH
3a-HA 
NO PCR  NA  NA NA  pCMV 
Vav2-SH3a-
HA  
NotI+kleno
w/SpeI 
pmRFP-
Vav2SH323-
HA 
BglII+kleno
w/SpeI 
pmRFP-
Vav2SH
3b-HA 
NO PCR NA   NA  NA NA  NA pmRFP-
Vav2SH323-
HA 
religation 
ScaI 
pmRFP-
Vav2SH
2-HA 
NO PCR NA   NA  NA pCMV 
Vav2-SH2a-
HA 
NotI+kleno
w/SpeI 
pmRFP-
Vav2SH323-
HA 
BglII+kleno
w/SpeI 
pmRFP-
HA 
NO PCR  NA  NA NA   NA NA pmRFP- 
Vav2SH323-
HA 
religation 
ScaI/SpeI+kl
enow 
pSig-
eGFP_IL
2Rcg_Δ5
0-Δ80  
pSigEGFP
_hIL2Rcg
_Flag 
IL2Rcg-
seqF1 
 50-80 
rev 
pJet 
IL2Rsh
ort  
pJet 
IL2Rshort   
BstXI/XhoI pSigEGFP_h
IL2Rcg_Flag 
BstXI/XhoI 
pC2_IL2
R_eGFP
_Δ50-
Δ80 
pSigEGFP
_hIL2Rcg
_Flag 
IL2Rcg-
seqF1 
 50-80 
rev 
pJet 
IL2Rsh
ort  
pJet 
IL2Rshort   
BamHI/Xho
I 
pC2-IL2Rg-
EGFP 
BamHI/BstX
I 
pcs2+2x
mem-cg-
cyt-GFP 
pNhis_IL
2Rcg_EG
FP   
GFP rev 
BglII 
cg cyt 
fwd 
BspEI 
pJetcg-
cyt-
GFP 
pJetcg-cyt-
GFP 
BspEI/ BglII pCS2+mem
Cerulean 
AgeI/BglII  
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2.1.3 Primer sequence 
 
50_rev 
TGGATCCGCCTCGAGCTCACTGACGAG
GC 
60_rev TGGATCCGCCTCGAGCTCCCCAAG 
70_rev TGGATCCGCCTCGAGATGCTGGTTGCA 
80_rev TGGATCCGCCTCGAGGGTGTAACATGG 
FW2 (Y172D) GACGACATCGACGAGGACATC  
RW2   GATGTCCTCGTCGATGTCGTC  
FW3 (Y142D) CGATGACGTCGACCGCAGCC   
RW3 GGCTGCGGTCGACGTCATCG  
FW4  (Y159D) GGGGAGGACATCGACGACTGC  
RW4   GCAGTCGTCGATGTCCTCCCC  
IL-2R_seq_F1 TCCCAGAGGTTCAGTGTTTTGTGT 
SH3_1 rev SpeI ACTAGTAGGGCAGGGCTTCAC 
CMV fwd ATGGGAGTTTGTTTTGGCAC 
GFP rev BglII AGATCTTTACTTGTACAGCTCGTC 
cg cyt fwd BspEI TTTCCGGATAACCTAGAGGATCTTGTT 
Linker rev Spe1 ACTAGTG CAGTTCCTCTTGTC 
Vav2-Y174D FW GACGACATCGACGAGGACATC 
Vav2-Y174D RW GATGTCCTCGTCGATGTCGTC 
Vav2-Y142D FW CGATGACGTCGACCGCAGCC 
Vav2-Y142D RW GGCTGCGGTCGACGTCATCG 
Vav2-Y160D FW GGGGAGGACATCGACGACTGC 
Vav2-Y160D RW GCAGTCGTCGATGTCCTCCCC 
 
2.1.4  esiRNA sequence 
 
Vav2 
(EHU058751) 
CCCGAGATATGAGGGAGCTTTCGCTGCGGGAGGGTGACGTGGT
GAGGATCTACAGCCGCATCGGCGGAGACCAGGGCTGGTGGAAG
GGCGAGACCAACGGACGGATTGGCTGGTTTCCTTCAACGTACG
TAGAAGAGGAGGGCATCCAGTGACGGCAGGAACGTGGACAAG
ACTCGCAGATTTTCTTGGGAGAGTCACTCCAGCCCTGAAGTCTG
TCTCTAGCTCCTCTGTGACTCAGAGGGGAAATACCAACCT 
RULC 
(esiRNA1) 
GATAACTGGTCCGCAGTGGTGGGCCAGATGTAAACAAATGAAT
GTTCTTGATTCATTTATTAATTATTATGATTCAGAAAAACATGC
AGAAAATGCTGTTATTTTTTTACATGGTAACGCGGCCTCTTCTT
ATTTATGGCGACATGTTGTGCCACATATTGAGCCAGTAGCGCGG
TGTATTATACCAGACCTTATTGGTATGGGCAAATCAGGCAAATC
TGGTAATGGTTCTTATAGGTTACTTGATCATTACAAATATCTTA
CTGCATGGTTTGAACTTCTTAATTTACCAAAGAAGATCATTTTT
GTCGGCCATGATTGGGGTGCTTGTTTGGCATTTCATTATAGCTA
TGAGCATCAAGATAAGATCAAAGCAATAGTTCACGCTGAAAGT
GTAGTAGATGTGATTGAATCATGGGATGAATGG 
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2.1.5  Antibodies 
 
Antibody Experiment Dilution Species Primary/Secondary Company 
      
Anti- eGFP WB 1:4000 Rabbit Primary Clonetech 
632460 
Anti- HA WB 1:2000 Mouse Primary Cell signaling 
2367S 
Anti- 
GAPDH 
WB 1:4000 Mouse Primary Abcam 
Ab8245 
Anti- Stat6 WB 1:2000 Rabbit Primary Santacruz 
Sc-136019 
Anti-pStat6 WB 1:4000 Mouse Primary Santacruz 
Sc-11762 
Anti-VAV2 WB 1:2000 Rabbit Primary Abcam 
Ab52640 
Anti-
pVAV2 
WB/ICC 1:1000/1:400 Rabbit Primary Santacruz 
Sc-16409 
Anti-Rabbit WB 1:4000 Donkey Secondary GE Healthcare 
NA9340 
Anti-Mouse WB 1:4000 Goat Secondary Sigma 
A8924 
Anti-Vav3 WB 1:2000 Rabbit Primary ab52938 
Anti-EEA1 ICC 1:400 Mouse Primary BD bioscience 
BD610456 
Anti-HGS ICC 1:400 Rabbit Primary Gene tex 
GTX101718 
Anti-mouse ICC 1:1000 Goat Secondary Invitrogen 
Anti-Mouse ICC 1:1000 Goat Secondary Invitrogen 
WB: Western Blot, ICC: Immunocytochemistry 
 
2.1.6  Solutions and media: 
 
Solution and media Composition 
PEM 80mM PIPES, 5mM EGTA, 1mM MgCl2, pH 7.4 
Semi dry buffer 200ml MeOH, 0.37g SDS, 5.81g TRIS, 2.39g Glycin, add H2O up 
to 1 liter 
PBS 1.7mM KH2PO4, 5.2mM Na2HPO4, 150mM NaCl 
PBST PBS,  0.05% Tween 
5% milk 5% (w/v) powdered, non-fat, dry milk in PBST 
Air buffer 150mM NaCl, 20mM HEPES pH 7.4, 15mM Glucose, 46mM 
Trehalose, 5.4mM KCl, 0.85mM MgSO4, 1.7mM CaCl2, 
0.15mg/ml bovine serum albumin 
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10X SDS buffer 10g SDS (0.1% w/v) , 30g TRIS (25mM) , 144g Glycin (192mM)  for 1 
L H2O 
25% PFA 25 % (w/v) Paraformaldehyde solution in PEM 
PEMT PEM + 0.2% Tween 
Blocking buffer PEM + 0.2% tween + 0.5% BSA 
 
2.2 Methods 
2.2.1 Cell culture and maintenance  
 
HEK293 cells were kept as adherent culture in DMEM medium (Invitrogen/Gibco) 
supplemented with 10% FCS (Fetal calf serum). They were cultured with 5% CO2 at 37°C. 
Cells were passaged by trypsination. Cells were washed 1X with PBS and incubated for 2 
min at 37°C with trypsin. Trypsin was inactivated by the growth medium and removed by 
centrifugation. Cells were resuspended in DMEM medium and seeded in 3X10
4
 /ml in 25cm 
flask. Cells were passaged every third day.  
 
2.2.2 Cell seeding and transfection  
 
Transfection was done with a traditional protocol. Cells were seeded 24 hours before 
transfection so that they are 40% confluent on the next day. Cells were transfected with 
Turbofect (Life Technologies) using a DNA:Turbofect ratio of 100ng:0.3μl. For imaging 
purposes, 24 hours post transfection cells were washed twice with air buffer or media without 
phenol red to avoid the auto-fluorescence from Phenol red. 
 For esiRNA transfection, cells were seeded before 24hr so that cells are 20% confluent on 
next day. Next day cells are transfected with esiRNA:lipoRNAiMAX (Life Technologies) 
ratio of 100ng:0.2μl. After 48 hours, cells are transfected again with esiRNA and DNA mix 
together. Cells were lysed 24 hours later and analyzed by western blot. 
For immunostaining, FRAP and imaging experiments, 8-well Lab-tek chambers (Nunc) were 
used. For pull down assays, 6-well plates were used. For esiRNA experiments, 12-well plates 
were used. 
 
2.2.3 Cell fixation and immunostaining 
 
24 hour post transfection cells were washed twice with PEM and fixed with 4% PFA/PEM 
for 10 min, followed by 4% PFA/PEMT for 10min. Cells were washed 3X10min with PEMT. 
Cells were incubated with NH4Cl for 15 min and washed 2X10min with PEMT. Blocking 
was done for 30min at room temperature in blocking buffer. Cells were incubated with 
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primary antibody diluted in blocking buffer at 4°C overnight. Next day, cells were washed 
3X20min PEMT. Secondary antibody staining was done for 1 hr at room temperature 
followed by subsequent washing step with PEMT for 3X10min and PEM for 1X10min. Cells 
were imaged directly in PEM or embedded in Mowiol overnight and imaged next day.  
 
2.2.4 Cell lysis 
 
After 24 hours post transfection, cells were washed with PBS and lysed by Lysis buffer. 
Phosphatase inhibitors cocktail2 and cocktail3 (Sigma-Aldrich) and protease inhibitor 
(Roche, Complete EDTA free) were added to the lysis buffer. Cells were kept on ice with 
mixing in between for 30min followed by 10min centrifugation at 10,000g 4°C to sediment 
the cell debris.  Supernatant was taken in to a fresh tube and either processed for pull down 
assay or analyzed by western blot. 
 
2.2.5 Pull down 
 
 MACS epitope tag protein isolation kit was used according to manufacturer‟s instruction. 
After cell lysis 50 l anti-eGFP/HA tag micro beads were added to the cell lysate supernatant 
and incubated for 30min on ice with shaking in between. Cell lysate was applied to pre-
equilibrated µ columns placed in a strong magnetic field.  Column was rinsed with wash 
buffers and samples were eluted with 50 l elution buffer. Samples were analyzed by western 
blot. 
 
2.2.6 Western blot 
 
For the separation of proteins 10% or 12% or “anyKd” SDS polyacrylamide BioRAD gels 
were used.  
The lysates were boiled with 5x SDS sample buffer for 10 minutes at 95°C before they were 
loaded on the SDS-PAGE gel. The gels were run in 1x SDS running buffer with 120 V and 
300 mA for 20 min to stack the band. Subsequently, the voltage was increased to 160 V. The 
Precision Plus Protein
TM
 standard was purchased from BIO-RAD.   
For the immune-detection of the separated proteins, the proteins were transferred by western 
blotting using the Biometra Semi dry blotter. The cellulose blotting paper (VWR) and 
nitrocellulose membrane (Protran, 0.45 m pore size) was first soaked in blotting/transfer 
buffer for several minutes. These components were stacked air bubble free on the blotting 
cassette in the following order: lower side of the cassette (anode), cellulose paper, 
nitrocellulose membrane, gel, cellulose paper, upper side of the cassette (cathode). Proteins 
transferred for 1.5hrs at constant 45mA and maximum Volt. After blotting, the membrane 
 
 
19 
 
was blocked with 5% milk for 1 hour at room temperature. Then, the membrane was 
incubated with the primary antibody in 5% milk in 50 ml falcon tube for 1hr at room 
temperature or overnight at 4°C. The membrane was washed 4X5min with PBST before 
incubation with the secondary HRP-coupled antibodies in 5% milk for 1hr at room 
temperature. Again, the membrane was washed 4x10 min with PBST followed by 2X10min 
PBS to remove tween. The bioluminescence was detected with the LAS-3000 luminescent 
image analyzer (Fujifilm) using the ECL
 TM
 Western Blotting Analysis System (GE 
Healthcare). All washing and incubation steps were performed on a tumbler. 
 
2.2.7 IL-4 labeling 
 
For biotinylation- EZ-Link Sulfo-NHS-Biotinylation Kit (Thermo scientific, # 21425) was used. 
20nM of IL-4 was suspended in 500µl of BIC buffer. As per instructions, Biotin was 
dissolved in DMSO. Biotin-DMSO was added to the IL-4 having final concentration of 
400nM. IL-4-Biotin solution was incubated overnight at 4°C. Next day, buffer exchange was 
carried out to replace BIC with PBS using Nap5 column (GE Healthcare). Fractions were 
aliquoted in Eppendorf tubes containing 1% BSA. Fractions were analyzed by silver staining.  
 
 
Figure 2.1: Silver stained polyacrylamide gel of Biotinylated IL-4. Analysis of purified fractions 
after biotinylation. BSA was also added to the sample to prevent adsorption to eppendorf surfaces. 
 
2.2.8 Immunogold labeling and electron microscopy 
 
Cells expressing JAK3-GFP were fixed with 4% paraformaldehyde (PFA) in 0.1 M 
phosphate buffer (PB, pH 7.4) and processed for Tokuyasu cryo-sectioning as described [49, 
50]. Briefly, the cells were washed several times in PB, infiltrated stepwise into 10% gelatin 
and cooled down on ice. Small blocks (0.5 x 0.5 mm) were cut on ice, incubated in 2.3 M 
sucrose/water for 24hrs at 4°C, mounted on Pins (Leica # 16701950) and plunge frozen in 
liquid nitrogen. 70 nm sections were cut on a Leica UC6+FC6 cryo-ultramicrotome and 
picked up in methyl cellulose/sucrose (1 part 2% methyl cellulose (MC), Sigma M-6385, 25 
centipoises + 1 part 2.3M sucrose). For immunogold labelling, the grids were placed upside 
down on drops of PBS in a 37°C incubator for 20 min, washed with 0.1% glycin/PBS 
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(5x1min), blocked with 1% BSA/PBS (2x5min) and incubated with primary antibodies for 
1hr (anti-GFP: TP 401, Torrey Pines, 1:100). After washes in PBS (4x2min), the sections 
were incubated with Protein A conjugated to 10 nm gold for 1hr, washed in PBS (3x5sec, 
4x2min) and postfixed in 1% glutaraldehyde (5min). Sections were washed with distilled 
water (10x1min), stained with neutral uranyl oxalate (2% uranyl acetate (UA) in 0.15M 
oxalic acid, pH7.0) for 5min, washed shortly in water and incubated in MC containing 0.4% 
UA for 5 min. Finally, grids are looped out; the MC/UA film is reduced to an even thin film 
and air dried. Alternatively, the primary anti-GFP is detected with secondary antibodies 
coupled to ultrasmall gold (Aurion, ~ 1nm) followed by silver enhancement using the R-Gent 
SE/Kit (Aurion) before contrasting and embedding of the sections in MC/UA. Labelled 
sections are analysed on a Philips Morgagni 268 (FEI) at 80 kV and images were taken with 
the MegaView III digital camera (Olympus). 
 
2.2.9 Pulse chase experiment and drug inhibition 
 
A similar protocol was used for all pulse chase experiments, unless otherwise specified. 24hr 
post transfection, cells were kept on ice for 20min to cool down. The cells were then 
incubated with either 20ng/ml ligand IL-4 or 150nm A647 dye for another 20 min. Cells were 
washed 2 times with media to remove unbound ligand or dye and transferred onto a pre-
warmed metal block inside a 37°C incubator to initiate endocytosis. For inhibitor treatment, 
cells were incubated with inhibitors 50µM EHT-1864 and/or 10µM IPA3 for 10min before 
shifting them on ice, followed by same procedure as mentioned above in the presence of 
drug. Cells were either lysed after different time points and analyzed by western blot or fixed 
and imaged.  
For STAT6 kinetics assay, cells were transfected with 300ng pCMV-STAT6. For IL-4 ligand 
tracking experiment, cells were co-transfected with JAK3-eGFP (100ng), IL-2Rγ (100ng) and 
IL-4Rα (100ng). 
 
2.2.10 Loading Assay 
 
Cells were seeded sub-confluency in an 8-well chambered Lab-tek slide (Nunc) and co-
transfected with a DNA master mix. For IL-2Rγ kinetics, I transfected pNhis-IL-2Rγ -N2 
(80ng), pJAK3-eGFP (50ng) and pIL-4Rα -N1 (40ng). For IL-4Rα kinetics, cells were 
transfected with pIL-2Rγ -N1, pJAK3-eGFP and pNhis-IL-4Rα-N1 at equivalent 
concentrations in the absence or presence of 20ng/ml IL-4 (Life Technologies). The 
specificity of trisNTA-A647 binding was checked using receptors in which neither receptor 
subunit carried the His-tag. 
24 hours post-transfection, cells were washed twice with air buffer and kept at 4°C for 20min. 
After 20min, cells were incubated with 150nM trisNTA-A647 in air buffer for 20min on ice 
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to facilitate binding of dye to the His-tagged receptors. Cells were washed twice to remove 
unbound dye and transferred onto a pre-warmed metal block inside a 37°C incubator to 
initiate endocytosis. After different time points, cells were fixed with 4% PFA/PEM.  For the 
drug inhibitor treatment, the whole procedure was done in the presence of 50 µM EHT-1864 
with pre-incubation at 37°C for 10 min.  
Confocal imaging was performed on a LSM780 (Carl Zeiss, Jena, Germany) using avalanche 
photo diode detectors (APD). 16-bit images were recorded with a 40x, NA 1.2 water 
immersion objective, using a 75μm pinhole at a pixel dwell time of 50μs. eGFP emission was 
collected between 505-610nm, for A647 we used a 655nm long pass filter. Laser powers for 
both channels were adjusted such that the emission intensity did not exceed 1MHz. Each cell 
was imaged in three different planes (top, middle, and bottom) separated by 1.5µm. For 
image analysis, we manually selected the endosomes in the eGFP channel. A MATLAB 
script then identified the maximum intensity and extracted the total counts of a centred 3x3 
pixel bin (Matlab 2010a, MathWorks, Natick, MA, USA). Endosomes showing intensities 
exceeding the linear range were excluded. Average values for each individual cell (ca. 100 
endosomes) were then calculated for statistical analysis. Fitting of the loading and activity 
curves was performed using hyperbolic and logistic response functions as implemented in 
Origin 9.0 (OriginLab, Northampton, MA, USA). 
 
Fig 2.2: Schematic of loading assay. Cytokine positive endosomes are marked by Jak3-GFP. Using 
the his-tag binding TrisNTAAlexa647 to label the his-tag containing IL-4Rα or IL-2Rγ, the trafficking 
kinetics of the receptors can be assayed using colocalization analysis. 
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2.2.11 Fluorescence recovery after photobleaching (FRAP) 
 
FRAP experiments were performed on the LSM780 with a 40x, NA 1.2 objective using a 
multi-channel GaAsP detector to collect eGFP emission between 490 and 560nm. HEK293T 
cells were seeded sub-confluently in an 8-well chambered Lab-tek slides (Nunc) and co-
transfected with pJAK3-eGFP and pIL-2Rγ-N1. Region of interest (ROI) (2.5 x 2.5 µm
2
) 
were selected on the membrane plane, containing either plasma membrane or both plasma 
membrane and a cortical endosome. JAK3-eGFP was bleached to about 20% using the 
combined excitation of the 405 and 488nm laser lines. 50 frames over a period of 5min were 
recorded.  
The raw FRAP curves were normalized using the following equation: 
 ( )   
  
 ( )
   ( )                                                            (Equation 1) 
Where Ao is a prebleach intensity of the an area distant from the bleach area, A(t), the 
intensity with time during the experiment and B(t) the intensity with time at the area of 
bleaching. Then the normalized curve is given by: 
 ( )   
 ( )    
      
                                                                    (Equation 2) 
Where Bo is intensity at the area of bleaching before the bleaching, and C1 the first point after 
bleaching from equation 1. Curves are fitted with using following equation adapted from 
[51]:  y=A (1-e
-Bx
 )  . 
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Chapter 3 
 
 
 
 
 
 
 
Results part I: Characterization of the endosomes 
 
3.1 Preface 
 
In order to understand the role of endocytosis in cytokine receptor signaling we are studying 
this pathway in human embryonic kidney (HEK293T) cells, using the IL-4R receptor as a 
model [52, 53]. The IL-4R shares the IL-2Rγ chain with several other, related receptors, 
including the IL-2R and IL-7R receptor complexes, and this recruited subunits is hence also 
referred to as the common gamma chain [4, 54].  
The IL-4R can form three types of active receptor complexes, which can be induced either by 
IL-4 or IL-13. A type 1 receptor complex is formed when IL-4 binds to IL-4Rα and recruits 
the secondary receptor subunit IL-2Rγ. Type 2 receptor complexes comprise of IL-4Rα and 
IL-13Rα1, which can be assembled following binding of either IL-4 or IL-13.  
Although cytokine receptors can signal via many different pathways like insulin receptor 
substrate (IRS) or PI3K (Phosphatidylinositol 3-kinase), their main signaling output occurs 
via the JAK/STAT pathway. Signaling is generally thought to be initiated when ligand 
induces receptor dimerization on the plasma membrane where the ligand binding chain 
recruits the second receptor/co-receptor, which may be shared by several different receptor 
complexes [53, 55] (Figure 3.2). This brings associated JAKs into close proximity, which 
facilitates their cross-phosphorylation. This results in further phosphorylation of tyrosine 
residues on the receptor tail that provides docking sites for STAT family transcription factors. 
STATs are then phosphorylated on conserved tyrosine residues that facilitate their 
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dimerization. Finally, STAT dimers are translocated to the nucleus where they and bind to 
DNA motifs in the promoters of STAT-responsive genes.    
 
 
Figure 3.1: Schematic representation of two types of IL-4R complexes. Type 1 receptor complex is 
formed upon binding of IL-4 to IL-4Rα. This is followed by recruitment of co-receptor of IL-2Rγ. Type 
2 complex can be induced either by ligand IL-4 that binds to IL-4Rα and recruits IL-2Rγ or by ligand 
IL-13 that binds to IL-13Rα1 and recruits IL-4Rα as a co-receptor.  
 
Figure 3.2: JAK/STAT pathway. (1) Each receptor subunit consists of a receptor chain and its 
associated JAK kinase. (2) Ligand binding to the alpha chain triggers recruitment of a secondary 
subunit. This brings associated JAK kinases into sufficiently close proximity that facilitates cross-
phosphorylation. (3) JAKs furthermore phosphorylate tyrosine residues on the receptor tail. (4) 
Phosphorylated residues then provide a docking site for STATs. (5, 6) Phosphorylated STATs then 
forms a dimer and translocate into the nucleus, where they regulate target gene transcription.   
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All these receptors possess typical structural features of hametopoetin family - 4 conserved 
cysteine residues, fibronectin type II modules in its distal region from plasma membrane and 
tryptophan-serine doublet (WSXWS) in its proximal domain. Apart from that, IL-13Rα1 
contains an extra IgG-like domain at its N-terminus. These cytokine receptors do not have 
intrinsic catalytic activity and instead it is provided by their associated JAKs. IL-4Rα, IL-2Rγ 
and IL-13Rα1 are associated with JAK1, JAK3 and TYK2 respectively and signal, amongst 
other pathways, through STAT6 phosphorylation. Importantly, while IL-4R can also activate 
other STATs such as STAT5, which can also be controlled by other cytokine receptor, Stat6 
only responds to the IL-4R. So STAT6 phosphorylation gives specific readout of IL-4R 
signaling pathway. Upregulation of the IL-4R pathway is related to diseases like allergy and 
asthma [56], whereas either mutation in IL-2Rγ encoding gene or prevention of its 
association with JAK3 results in X-linked severe combined immunodeficiency (XSCID).  
We are studying IL-4R signaling pathway by reconstituting type 1 receptor complex in 
HEK293T cells. Because of their size and adherent nature, these cells are suitable for 
different microscopic techniques [47]. HEK293T cells express the endogenous type 2 
receptor components IL-13Rα1 and IL-4Rα but not the type 1 receptor components IL-2Rγ 
and JAK3. They also do not express signal transducer STAT6 which allow us to study 
pathway specific effects by transient expression of STAT [53]. By over-expression of the 
type 1 receptor component, we can re-route the entire pathway via type 1 signaling pathway 
and can ignore endogenous type 2 background [47]. The cytokine mediated signaling was 
reconstituted on Jurkat cells lymphocytes also and the results are similar to those in HEK 
cells (Kristina Kurgonaite, unpublished results). 
Initial results in the lab have shown that expression of the type1 signaling components in the 
HEK293T cells resulted in inhomogeneous distribution of the proteins at the plasma 
membrane. IL-4R subunits accumulated in speckle-like structures with strong fluorescent 
signals. These structures were suspected to be endosomes, which was confirmed by the 
presence of the endosomal marker proteins Rab5 and Rab11. The aim of this chapter is to 
reconfirm these initial results, and to further investigate and characterize these interleukin-
positive endosomal structures in detail. 
 
3.2 Endosome formation is ligand independent 
 
Previous studies in our lab have shown that JAK3 and IL-2Rγ expressed in HEK293T cells 
are mutually required for their plasma membrane localization [53, 57]. If IL-2Rγ is expressed 
alone, it is localized in perinuclear region, while expression of JAK3 on its own resulted in a 
cytoplasmic distribution. However, co-expression of IL-2Rγ recruits JAK3 to the plasma 
membrane and JAK3 in turn stabilizes IL-2Rγ on the surface (Figure 3.3A). Therefore, the 
co-expression of JAK3 and IL-2Rγ is essential for plasma membrane localization of these 
components. Moreover, we observed that their distribution is not homogenous and they form 
speckle-like punctate structures - endosomes (close arrows), characterized by bright 
fluorescent spots along the otherwise homogeneous plasma membrane. Due to the optical 
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resolution limit of confocal microscopy, it is not clear from fluorescent images whether they 
are distinct endosomal structures close to the cell surface or protein accumulations within the 
plasma membrane (Figure 3.3B). Tagging of receptors or kinase with fluorophores does not 
interfere with endosome formation or protein expression. Surprisingly, these endosomes are 
formed in the absence of ligand. Since JAK3 is always a component of the speckle-like 
structures, I used JAK3-eGFP as a positive endosomal marker.  
 
Figure 3.3: Co-expression of JAK3 and IL-2Rγ in HEK293T cells. Left panels, (A) JAK3 shows 
cytoplasmic distribution (a), IL-2Rγ is localized in perinuclear region in the absence of JAK3 (c). 
Open arrow shows no recruitment of IL-2Rγ or JAK3 to the surface. (b) and (d) shows co-expression 
of JAK3 and IL-2Rγ makes endosomal structure on the membrane, shown by close arrows. Open 
arrow shows homogenous distribution in the plasma membrane. (B) Close-up image of the endosomal 
structure along the plasma membrane. 
After confirming that type 1 complex reproducibly localizes to endosomal structures, we 
checked whether the type 2 receptor subunit -IL-13Rα1 also colocalized within the same 
JAK3-positive endosome. To directly and  simultaneously visualize multiple receptors that 
are present on the plasma membrane in the absence of ligand, receptors carrying an N-
terminal His-tag was used that can be labeled with trisNTA-conjugated fluorescent dyes. The 
Ni
2+
-trisNTA complex moiety has a low nanomolar affinity towards the hexa-histidine 
stretch. The N-terminus of the extracellular cytokine-binding domain carrying the hexa-
histidine is distant from the IL-4 binding site. Therefore, trisNTA labeling does not interfere 
with cytokine binding[47]. To stain the surface expressed H6-IL-2Rγ, cells were incubated 
with Tris-NTA-A647 at 4°C (where the membrane dynamics are inhibited) and washed to 
remove unbound label before endocytosis was started by a shift to 37°C.  
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Confocal images showed that the type 1 receptor subunit IL-2Rγ, and the type 2 receptor 
subunit IL13Rα1 is accumulated in the same endosomal compartment (Figure 3.4). Taken 
together, these results show that IL-13Rα1 colocalizes with IL-2Rγ and JAK3 within the 
same endosome population independent of ligand induction. 
 
Figure 3.4: Type 1 and 2 receptor subunits accumulate in the same endosomal compartment. 
IL13Rα1-eGFP (A) co-localize with JAK3-TagRFP (B) and H6-IL2Rγ (C) in endosomes (arrow 
heads). (D) Shows the overlay image. Square insets show zoomed in image of endosomal co-
localization of type 1 and type 2 receptor subunits. Scale bar 10 m 
 
3.3 IL-2Rγ positive cortical endosomes are multi-vesicular bodies 
 
Fluorescence imaging has a limited spatial resolution. To characterize the endosomes at the 
ultrastructural level, Transmission Electron Microscopy (TEM) was performed with various 
sets of labeling on cells expressing type 1 receptor complex. These experiments were 
performed in collaboration with the Electron Microscopy Facility (EMF) of the CRTD. As 
ligand endocytosis is specific to the endosomes; IL-4-biotin gold labeling was used to 
visualize the IL-4 localization on the endosomes.  IL-4 ligand was labeled with biotin through 
a Sulfo-NHS linker so that tagging does not interfere with the binding of IL-4-biotin to IL-
4Rα. To avoid fluid phase uptake, cells were incubated with IL-4-biotin at 4°C. Cells were 
washed to remove unbound IL-4-biotin and incubated at 37°C to allow the internalization of 
IL-4Rα-bound IL-4-biotin. 
Before proceeding for the EM, the endosomal localization of IL-4-biotin was verified by 
fluorescence confocal imaging using Cy3-streptavidin. Transfected cells incubated with Cy3-
streptavidin in the absence of IL-4-biotin do not exhibit any non-specific binding of 
Streptavidin to the membrane or JAK3-eGFP-positive speckles (Figure 3.5A) However, in 
cells stimulated with IL-4-biotin, Cy3 streptavidin showed colocalization with JAK3-positive 
endosomes as shown by arrow heads (Figure 3.5B). 
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Figure 3.5: IL-4-biotin specificity. (A) Cy3 streptavidin staining on transfected cells does not show 
non-specific binding to the membrane or endosomes (open arrow). (B) In cells stimulated with IL-4-
biotin, Cy3 streptavidin specifically binds to IL-4-biotin (A) and therefore colocalizes with JAK3-
eGFP (B) and IL-2Rγ (C) positive endosomes, shown by arrow heads. Scale bar 10 µm.     
 
Figure 3.6: Representative images of fluorescent image of fix sections on grid. (A) Cells expressing 
JAK3-eGFP. (B) Nuclei are counterstained with DAPI. (C) Overlay of both GFP and DAPI channel. 
Appropriate samples are selected from the fluorescent image and imaged by TEM.  
As we had previously established that JAK3-eGFP is always a marker for the endosome, 
fluorescent images were taken to identify cells expressing JAK3-eGFP. From the same 
samples, corresponding TEM images were taken to reveal the ultrastructure of the eGFP-
positive cortical endosomes.  
Cells were stimulated with IL-4-biotin for 30min. After internalization of the ligand, cells 
were fixed, embedded in 10% gelatin, infiltrated in 2.3 M sucrose and subsequently frozen 
into liquid nitrogen. 70nm thin Tokuyasu cryo-sections were thawed and placed on a grid for 
immunogold staining[49]. Because streptavidin-gold did not work, the sections were finally 
stained with anti-biotin and protein A, conjugated with 10 nm gold. TEM images shows that 
endosomes are multivesicular bodies (MVB) lying just beneath the plasma membrane (Figure 
3.7).  
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Figure 3.7:  TEM image of gold labeled IL-4 marking endosome. (A) Endosome labeled with 10nm 
gold labeled IL-4-biotin beneath the plasma membrane (Black dotted line). Scale bar 200 nm. (B) 
Close up image of endosome showing multivesicular structure. (C) Endosome labeled with 10 nm 
gold labeled IL-4-biotin. 
To directly detect JAK3 and IL-2Rγ in the multivesicular endosomal structures, we 
proceeded to JAK3-eGFP staining. Cells expressing JAK3-eGFP and IL-2Rγ were fixed, 
infiltrated, frozen and 70nm sections were taken. Sections were stained with primary anti-
GFP and were detected with secondary antibodies coupled to ultra-small gold ~1nm, 
followed by silver enhancement. Antibodies conjugated to ultra-small gold particles can 
diffuse into the section which results in stronger labeling, because the signal is not confined 
to the surface but present throughout the section. These samples revealed that JAK3-eGFP is 
present on the limiting membrane and internal vesicles of the endosome as well as on the 
plasma membrane. The IL-2Rγ subunits marked by JAK3-eGFP appear to be enriched in 
multivesicular endosomes beneath the plasma membrane. However, this method could not be 
used for quantification because diffusion into the section is not homogenous and therefore the 
antigens are not equally accessible. 
 
Figure 3.8: TEM image of JAK3-eGFP nano gold particle enhanced with silver labeling. Black 
dots represent the gold particle that is present on the limiting membrane, on internal vesicle as well 
as on the plasma membrane. Black dotted line represents the plasma membrane. Unlike the standard 
gold particle, size of this gold particle is unequal due to silver enhancement. Blue arrow shows 
different sizes of gold particles. Scale bar 200nm. 
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For the quantification of gold particles to estimate receptor density, the sections were 
therefore labeled with larger gold particles that do penetrate into the section. As a result, the 
staining is weaker than in silver enhanced samples, but because the labeling is confined to the 
section surface all surface antigens are equally accessible, making these samples suitable for 
quantification. Thawed cryo-sections were stained with primary anti-GFP and protein A-
10nm gold instead of ultra-small gold.  
 
Figure 3.9: Quantification of gold particles. (A) Sections were stained with anti-eGFP antibody and 
detected by 10nm gold particles. Black dotted line represents length of plasma membrane. Open 
arrow shows gold particle on the plasma membrane. Black dotted line represents membrane 
surrounding the endosome and intravesicular bodies. Close arrow shows JAK3-eGFP labeled with 
10nm gold particles. (B) Close up image of gold-labeled endosome (C) Quantification of IL-
2Rγ/JAK3-eGFP complexes at the limiting membrane of endosomes (CE/LM) and on the plasma 
membrane (PM). Error bars indicate SD.  
To quantify the densities, total length of the plasma membrane and number of gold particle 
present on the membrane were calculated. For endosomes, the length of the surrounding as 
well as inner vesicles membranes was measured and the numbers of gold particles present on 
them were counted. Receptor density was correlated to the number of gold particles. This 
corresponds to about 8 times higher density of JAK3-eGFP per unit length of membrane in 
the endosome compared to the adjacent plasma membrane, clearly showing that the receptors 
are enriched in the cortical endosomes.  
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Cortical endosomes 
 
Plasma membrane 
 
Image 
 
# gold total 
 
# gold LM 
 
[µm] membrane 
 
# gold 
 
[µm] membrane 
1 6 4 1.1 1 3.5 
2 4 3 1.2 1 1.8 
3 4 3 1.8 0 2.2 
4 4 1 0.8 1 3.2 
5 1 1 1.5 0 3.3 
6 3 3 0.8 0 1.9 
7 2 1 1.5 2 2.8 
8 3 1 1.6 0 2.0 
9 4 3 2.4 0 2.7 
10 4 4 0.9 0 1.3 
11 1
0 
3 1.2 3 3.0 
12 6 2 1.4 2 3.1 
13 4 4 1.4 1 1.2 
14 1
7 
6 1.4 3 3.4 
15 7 7 0.8 4 3.6 
16 4
6 
3
3 
3.3 16 12.3 
17 1
4 
1
4 
1.1 5 2.4 
18 1
4 
1
4 
0.7 4 4.6 
19 1
4 
1
2 
1.4 4 3.1 
20 8 8 0.9 2 2.8 
21 3
7 
3
0 
3.8 18 17.2 
22 4
6 
3
6 
2.0 13 7.4 
23 1
6 
1
2 
2.2 7 3.6 
24 1
3 
1
1 
0.8 4 3.8 
25 9 6 1.5 1 1.9 
 
Table 1: Quantification of immunogold labeled IL-2Rγ/JAK3-eGFP complexes in the membrane by 
TEM. Gold particles were counted in cortical endosomes in total and at the limiting membrane as 
well as at the plasma membrane of the same image.  
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3.4 Multivesicular bodies are associated with actin meshwork: 
 
As previously observed, IL-2Rγ is known to be endocytosed via a specific actin-mediated and 
dynamin-dependent but clathrin- and caveolin-independent pathway[58, 59][58, 59][58, 
59][58, 59][58, 59][58, 59]. This endocytosis route requires the activation of the Rho-family 
GTPase Rac1, the p21-activated kinase (Pak1/2), and cortactin, leading to locally confined 
actin reorganization[37-41]. To determine whether the JAK3-eGFP labeled endosomes are 
associated with actin, CLEM (correlative electron microscopy) labeling was performed using 
anti-GFP immunofluorescence as a means to identify cortical speckles and anti-actin protein-
A gold labeling to detect cortical actin in the vicinity of the cortical endosomes. For this, cells 
expressing JAK3-eGFP/IL-2Rγ were fixed and sectioned. Cryo-sections were stained with 
primary antibodies against GFP and actin, followed by fluorescence and gold probes, 
respectively. In agreement with this mechanism, image shows that IL-2Rγ/JAK3-eGFP 
positive endosomes are surrounded by gold labeled cortical actin (Figure 3.10G).  
 
 
Figure 3.10:  CLEM of JAK3-eGFP expressing cells. Sections were labeled with anti-GFP and anti-
actin antibodies which were detected by fluorescence and gold particles, respectively. Nuclei were 
counterstained with DAPI. (A) Overview, fluorescence, the cells of interest (ROI) are highlighted by 
arrowheads, the square indicates the region displayed in C. (B) overview ROI in the TEM, ROI 
indicated by arrowheads. (C) GFP-labeled cells, two of which are selected for CLEM (square). (D), 
(E) correlative imaging of two labeled cells in the FLM (D) and the TEM (E). The arrows indicate a 
JAK3-eGFP labeled speckle; the square indicates the region displayed in F. (F) higher magnification, 
the arrow indicates an electron dense structure underneath the plasma membrane; the square 
indicates the region displayed in G. (G) Multivesicular body in close proximity to the actin-labeled 
cell cortex. 
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Collectively, our TEM experiments shed light on three important points. First, the cortical 
endosomes are multivesicular bodies. Second, endosomes are anchored in the actin cortex 
just below the plasma membrane, from which they are separated by only approximately 20-
30 nanometers. Third, in the sections, receptor density per unit length is approximately one 
order of magnitude higher within the limiting membrane of the endosome than on the plasma 
membrane. Because the actual endosomal surface is two dimensional, this ratio corresponds 
to a roughly 100-fold increase in receptor density per area.  
 
3.5 Multivesicular bodies are positive for Hrs 
 
Although previous results in lab confirmed that these endosomes are early recycling 
endosomes as they stain positive for Rab5 and Rab11 (Kristina Kurgonaite, unpublished 
data), TEM images showed consistently that these endosomes are multivesicular bodies 
(MVBs). MVBs are characterized by the accumulation of small intraluminal vesicles within 
the endosome by invaginating towards the lumen from endosomal membrane. MVB 
formation is an intermediate step in endosome biogenesis where endosome matures from an 
early endosome to lysosome. Formations of MVBs is known to be mediated by Hrs 
(hepatocyte-growth-factor-regulated tyrosine kinase substrate) and ESCRT-1 (endosomal 
sorting complex required for transport-1) complex. Through its FYVE domain, Hrs is 
localized on to early endosome and during the process of invagination, it assimilates 
receptors destined for late endosomes or lysosomes [60]. Consistent with TEM 
immunostaining of these endosomes, most of these endosomes are positive for Hrs. Majority 
of the endosomes are also positive for both Hrs and EEA1 (early endosome antigen 1) 
(Figure 3.11). An interesting observation is that although they show a mixed characteristic of 
early, recycling and multivesicular nature they lay very close to the plasma membrane in 
actin cortex.  
 
Figure 3.11: Co-immunostaining of JAK3-eGFP positive endosome with Hrs and EEA1. (A) JAK3-
eGFP-positive endosome upon co-expression of JAK3 and IL-2Rγ. (B) EEA1 colocalized with JAK3-
eGFP positive endosome. (C) Hrs staining for JAK3-eGFP positive endosome. (D) Overlay image 
showing endosomes positive for both early endosomal marker – EEA1 and late endosomal marker 
Hrs. Square inset shows colocalized endosomes. Scale bar 10 µm. 
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3.6 Endosomes are separate compartments  from the plasma membrane 
 
The endosomal structures appear adjacent to the membrane in confocal images. However, 
due to small size of the endosome that is approximately 300nm (from TEM) which borders 
on the limit of optical resolution, and because TEM delivers only single sections, it is not 
possible to distinguish whether these endosomes are invaginations of the plasma membrane 
or distinct compartments. Therefore, we performed Fluorescence Recovery After 
Photobleaching (FRAP) to establish whether or not they are continuous with the plasma 
membrane by looking at the lateral diffusion of fluorescently marked receptor complexes. In 
FRAP, fluorescent molecules are specifically bleached in a sample region using lasers. Upon 
bleaching, depending on the mobility or any other active processes, the bleached molecules 
are replenished dominantly by unbleached fluorescent molecules, causing fluorescence to 
recover. The rate and extent of this replenishment of fluorescent molecules are quantified 
from time-lapse imaging. From the characteristics of the recovery curve, two important 
information can be deduced – the rate of recovery and the saturation level of recovery. The 
rate of recovery signifies how fast the fluorescent molecules are being exchanged. This is fast 
for molecules diffusing freely in the cytoplasm, slightly slower for molecules diffusing 
laterally within membranes, and can even slower or entirely absent for molecules rigidly 
attached to the ECM or cytoskeleton. The saturation of recovery depends on the immobile 
fraction of molecules which do not exchange in the sample. Typical images of bleaching 
experiments performed on cells are shown in Figure 3.12. In our case, it was not possible to 
bleach the endosomes exclusively, as they lay very close to the plasma membrane. Therefore, 
FRAP was performed either on regions of homogenous plasma membrane or on membrane 
containing an underlying endosomal structure. We found diffusion time/recovery time 
constants of 45s in a region containing only plasma membrane and 66s for a region 
containing a labeled endosome close to the plasma membrane (Figure 3.13). These recovery 
times are consistent with the lateral diffusion in the plasma membrane [61, 62].  
However, when comparing recovery saturation we found that the immobile fraction is lower 
in regions containing only plasma membrane fluorescence (ca 45%) than in regions 
containing a cortical endosome adjacent to the plasma membrane (78%).  It is very difficult 
to measure the contribution of the plasma membrane in the recovery observed in regions with 
both endosome and plasma membrane owing to optical resolution limit. However, over the 
time of the experiment, no reconstitution of the endosomal fluorescence could be observed 
(Figure 3.12). We therefore interpret the increased immobile fraction as a result of the failure 
to traffic receptor complexes to the endsomes with comparable speed. Furthermore, this 
excludes the fast recovery of JAK3 between receptor bound and cytoplasmic free pool, that 
also resembles with JAK1 dynamics [63]. Thus, the majority of IL-2Rγ/JAK3-eGFP 
complexes within these endosomes are not in diffusive exchange with the plasma membrane 
or the cytoplasmic pool within the time frame of the experiment.  
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Figure 3.12: Representative image of FRAP. Square shows region of interest (ROI) with 2.5 m2 on a 
membrane region (black outline) and membrane with endosome (red outline). While plasma 
membrane recovers, endosomes do not recover during observation time showing that they are 
disconnected from the plasma membrane.    
 
 
 Figure 3.13: FRAP Recovery. (A) FRAP curve shows that immobile fraction is increased in 
endosome containing region (red) than in membrane containing region (black). (B) Table 2: Fit 
values of plasma membrane and speckle region showing recovery is in similar time regime but 
immobile fraction is increased in endosome containing plasma membrane. n=10 cells, error bars 
indicate Standard Error of the Mean (SEM). 
To summarize this section, I have shown that co-expression of IL-2Rγ and JAK3 results in 
the formation of endosomes that are present beneath the plasma membrane and are separated 
by 20-30nm. TEM shows that these endosomes are associated with actin cortex beneath the 
plasma membrane. Both type 1 and type 2 IL-4R subunits are present in the endosome.  
These endosomes are also accessible by ligand. However, confocal and TEM images give 
information only about steady state, it does not elucidate the dynamics of the transport of 
receptor molecules into the endosome from the plasma membrane. To understand receptor 
trafficking and measure the temporal dynamics of receptor endocytosis and signaling, 
quantitative live cell approaches need to be adopted.  
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Chapter 4 
 
 
 
 
 
 
  
Results II: Quantitative analysis of trafficking of Interleukin receptors 
 
4.1 Preface 
   
Endocytosis was generally thought as a process of down regulating receptor-mediated 
signaling, by reducing the accessibility of the receptors to ligands. Increasing evidence 
suggests that endocytosis and signaling may be coupled and endocytosis contributes 
synergistically to signaling. This has led to the “signaling endosome hypothesis”. There are 
many endocytosis pathways known and one of the thoroughly studied pathways is clathrin-
dependent pathway. For many years, it was believed to be the most common pathway for 
receptor-mediated endocytosis. However, more recently the involvement of clathrin-
independent pathways has been established [64]. These pathways are characterized by 
markers like GPI-anchored proteins and are used by autocrine mobility factor, TGF-β 
receptor, IL-2Rβ, toxins and viruses [38]. It is also reported that IL-2R subunits are clustered 
in lipid ordered microdomains , also called “rafts”, from where they are internalized by a 
clathrin-and caveolae-independent pathway[39]. This pathway requires Dynamin for scission 
of the vesicles from the plasma membrane. Internalization of the IL-2R subunits is regulated 
by the Rho family GTPase Rac1, which in turn controls the canonical actin polymerization 
and branching cassette comprised of Pak1/2, cortactin, WASP and the actin branching 
modulator Arp2/3.      
So far, I have shown that co-expression of JAK3 and IL-2Rγ forms endosomes and both type 
1 and type 2 receptor subunits are accumulated into these endosomes. These endosomes are 
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distinct compartments close to the plasma membrane and are surrounded by the actin cortex. 
Hence, we termed this population of signaling compartments “Cortical Endosomes”. 
However, these results give us only static images. To measure the dynamics of receptor 
endocytosis, the trafficking needs to be measured using live cell imaging. To achieve this, we 
labeled our proteins with different tags which allow us to visualize them simultaneously. As 
explained earlier, I used JAK3-eGFP as a marker for the cortical signaling endosomes. As 
explained in chapter III, receptors were again tracked with triNTA-A647 dye which 
reversibly binds to N-terminal His tag of the receptor [65, 66]. Depending on the 
experiments, Alexa647 labeled IL-4 ligand was also used [47]. 
 
4.2 Signaling components accumulates in the endosome 
 
To assay the dynamics of trafficking of receptors into these endosomes, a pulse chase 
experiment was performed which quantifies the uptake of the respective ligand bound to the 
receptor. 
Fluorescent Alexa-647 labeled ligand IL-4-A647 was used to track IL-4Rα receptor 
trafficking. Labeling of IL-4 with fluorescent dyes does not interfere with binding to IL-4Rα. 
In addition, labeled ligand specifically stains cells expressing the IL-4Ra subunit. Cells 
expressing type 1 receptor complex were incubated with IL-4-A647 at 4°C to avoid a 
background fluid phase uptake, while allowing efficient binding to surface expressed IL-4Rα. 
Cells were then washed to remove unbound IL-4-A647.  Endocytosis was then allowed to 
initiate by moving the cells to room temperature. Results show that at 0 min, while membrane 
dynamics remains blocked, because of low temperature, IL-4-A647 bound to the IL-4Rα is 
homogenously distributed in the cell membrane (Figure 4.1, b). However, after shifting the 
cells to room temperature, IL-4-A647 was accumulated in the endosomes within 7 min 
(Figure 4.1, e). The overlay shows clear co-localization of IL-4-A647 to the endosome 
marked by JAK3-eGFP+IL-2Rγ (Figure 4.1, f). We thus conclude that type 1 IL-4R subunits 
are transported into JAK3-positive endosomes from the plasma membrane.   
 
4.3 Dynamics of receptor trafficking in to the endosome 
 
We have shown morphologically using EM and using FRAP that the endosomes are distinct 
membrane compartments. We have also shown that IL-4: IL-4Rα complex  is trafficked into 
these endosomes. However, the receptors are also found localized to the endosomes 
independent of the ligand. In this section, using live cell imaging, we therefore want to 
answer the following questions: Whether a much slower process of replenishment of 
receptors occurs between the plasma membrane and the endosomes and whether the presence 
of ligands affects the kinetics of the trafficking.  
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Figure 4.1: Ligand co-localization in endosome. (A) Upper panel: At 0 min IL-4-A647 distribution is 
homogenous (b) and do not colocalize with JAK3-eGFP positive endosome (a) as shown in the 
overlay image (c). Lower panel: As the temperature is increasing, IL-4R bound IL-4-A647 is 
redistributed in to the endosomes within 7 min (e). Overlay image (f) shows at 7 min co-localization 
of IL-4-A647 with JAK3-eGFP positive endosomes (d). (B) Schematic of Type 1 receptor complex. 
Scale bar 5 µm.  
To determine the trafficking kinetics of receptors into endosomes, we designed a receptor 
loading assay which quantifies accumulation of ligands and receptor into the cortical 
endosomes at different time points. To establish whether receptor trafficking dynamics are 
affected by the IL-4 ligand, the receptor was labeled independent of the ligand using a His-
tag specific dye which binds to the hexa-histidine tag on the N-terminus of the receptors. 
Cells expressing type 1 IL-4R components were incubated with trisNTA-A647 dye at 4 °C for 
proper binding to the His-tagged receptors. Cells were washed to remove unbound dye and 
transferred to 37°C to resume endocytosis. To check the background due to unspecific 
binding of trisNTA dye, the same procedure was followed with cells transfected with 
receptors lacking the hexa-histidine tag. Cells were fixed after incubation for a particular time 
period, and were imaged with a confocal microscope. Confocal images were quantified to 
assay the receptor uptake.  
The intensities of the internalized receptor were quantified for each endosome. Since at initial 
time points, the intensity of the externally added labeled ligand is very low, the endosomes 
were in parallel marked by JAK3-eGFP. To measure the trafficking of receptor components 
in the endosomes, intensity from the pixels were calculated in the red channel that 
corresponds to the pixel area in the green channel. To calculate the concentration of 
internalized receptor and ligand, we measured the average intensity of a 3x3 pixel area shown 
by black inset within the endosome (Figure.4.2). Each endosome was selected manually and 
intensity was calculated by an automated MATLAB script.  
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Figure 4.2: Size of quantification within the endosome. (A) Co-expression of JAK3-eGFP and H6-
IL-2Rγ forms endosomes near the plasma membrane. Circle around the endosome depict that they are 
of different size. Figure B, C, D shows close up image of endosome. Black square shows the area 
within the endosome measured to quantify the intensity.  
It is important to set the conditions of imaging so that the range on intensities to be measured 
in the experiment lies in the linear range of the detectors. To ascertain this, different laser 
powers were used to measure the intensities. Counts per pixel measured from endosomes 
were plotted as histogram. The range of counts per pixel was 0-25 for 1% laser power and 0-
70 for 1.5% laser power. For a pixel dwell time of 50 µs was chosen for all the experiments 
as the measurements at 1% laser power at this setting were within the linear range of APD, 
which is about 500 KHz. This specification allowed us to measure accurately the trafficking 
of fluorescent ligand or receptor into the endosome.  
 
Figure 4.3: Histogram of counts/pixel at different laser power. Cells were imaged with two sets of 
different laser power. (A) With 1% laser power, the measured counts are between 0-35 with maximum 
counts around 10-15. (B) With 1.5% laser power, the counts are between 0-80 with maximum counts 
around 35. For the experiments, 1% laser power was selected as with this laser power, the counts are 
within linear range of APD around 500 KHz.  
Figure 4.4A shows example image of loading of labeled receptors at 0 min and 30 min in 
JAK3-eGFP positive endosomes. At 0 min, there is no accumulation of receptor H6-IL-
4Rα/H6-IL-2Rγ in red channel (Figure 4.4b). However, the endosomes become saturated 
with receptor H6-IL-4Rα/H6-IL-2Rγ within 30 minutes (Figure 4.4e). The square inset shows 
in the green channel the area within the endosome from which the photon intensity in red 
channel wass calculated. These intensities, which represent the uptake of receptors, were then 
plotted against different time after temperature release. 
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Figure 4.4: Representative image of Loading Assay. (A) 0min panel: at 0min no receptors are 
detectable in the Alexa647 channel (b) within the JAK3-positive endosomes (a). 30min panel: at 
30min JAK3-positive endosomes (d) are saturated with alexa647-labeled receptors (e). Square inset 
within the endosome shows area of intensity measurement. Panels (c) and (f) show the overlay. (B) 
Schematic of receptor complex with N-terminally His-tagged receptors which are labeled with 
TrisNTA dye.  
First, we checked the background intensity of the His tag dye for similar concentrations used 
for the experiments. The intensity of endocytosed IL-4Rα is normalized to the average 
intensity of H6-IL-2Rγ.  The saturation level of IL-4Rα is 30% of IL-2Rγ. The nonspecific 
background measured with just the dye is 10% (Figure 4.5). This confirms that experimental 
procedure using His tag dye is functional and can be used.  
 
Figure 4.5: Nonspecific background of His tag dye. Intensity of tris-NTA is calculated after 30min 
incubation from JAK3-eGFP positive endosomes. Intensity of IL-2Rγ is taken as 100%. Compare to 
IL-2Rγ, IL-4Rα has 30% background and 10% unspecific background. Error bar indicates SEM. 
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4.4 Receptor trafficking is independent of the type of receptor  
 
Next, we compared the trafficking rate of IL-4Rα and IL-2Rγ in the absence of ligand. As 
measured from the pulse chase experiment, IL-4Rα and IL-2Rγ are trafficked into the 
endosome with similar time constants of 8.5 ± 1.3min and 6.6 ± 0.7 min respectively (Figure 
4.6). The only difference between IL-4Rα and IL-2Rγ is in their saturation level. This 
saturation difference is presumably due to the difference in the expression level of receptors 
under physiological condition. The quantification of the trafficking shows that even though 
the endosomes appear as stable structures, they accumulate receptors continuously. The 
timescales of this trafficking is about 10 minutes, and therefore, too slow to be detected by 
FRAP assays. The loading experiments, however, strongly establish that there is a slower 
process of continuous trafficking of receptors occurring, which replenishes the endosomes. 
 
 
Figure 4.6: Trafficking kinetics of IL-4Rα and IL-2Rγ.  Both receptors shows similar trafficking 
rate but they have difference in saturation levels. Error bar indicates SEM. 
4.5 Receptor trafficking to the endosomes is independent of the presence of IL-4 
 
The classical assumption is that binding of ligands to receptors activate them to trigger 
internalization. Therefore, we wanted to confirm whether the continuous trafficking between 
the plasma membrane and the cortical endosomes is affected by the presence of ligand. We 
checked the internalization of IL-4Rα in the presence and absence of ligand. Intensity of 
accumulated TrisNTA-A647 in each endosome was calculated for different time points and 
plotted against time. The graph shows that the trafficking rate of IL-4Rα is 8.5 ± 1.3 min in 
the presence of ligand (Figure 4.7). Surprisingly, the rate of internalization for IL-4Rα was 
measured to be similar in the absence of ligand. Therefore, the IL-4Rα internalization is 
independent of ligand occupancy and does not require pre-dimerization with IL-2Rγ, which is 
 
 
42 
 
dependent on ligand binding. Considering these characteristics of the receptor trafficking, the 
model which emerges is that of the receptors acting like a “conveyor belt” shuttling the 
ligand constantly into the endosome.  
 
Figure 4.7: Trafficking kinetics of IL-4Rα. Trafficking rate of IL-4Rα is similar in presence and 
absence of ligand. Error bar indicates SEM. 
4.6 Signaling and receptor internalization is sensitive to perturbation of 
Rac1/Pak1 driven endocytosis  
 
As previously described, endocytosis of IL-2Rγ occurs via a Rac1/Pak1 regulated pathway. 
As IL-4Rα shares the common γ chain, we hypothesized that a similar pathway of trafficking 
using Rac1/Pak1 for IL-4R complex subunits as well. Indeed, previous results from the lab 
showed that IL-4R mediated signal transduction was sensitive to Rac1 or Pak inhibition. 
However, it was not clear the trafficking of which signaling components was affected. We 
therefore performed a pulse chase experiment in the absence or presence of Rac1 inhibitor 
EHT-1864[67].  Cells were pre-incubated with EHT-1864 at 4°C for 20min. IL-4-A647 was 
then added to the cells in the presence of drug for binding to IL-4Rα. After IL-4-A647 
incubation, cells were washed to remove unbound ligand but the presence of drug was 
continued while endocytosis was allowed to resume at room temperature. For the control, 
same procedure was followed in the absence of drug. As indicated by closed arrows in Figure 
4.8A, IL-4-A647 is colocalized with JAK3-eGFP endosome in absence of EHT. IL-4Rα 
mediated uptake of IL-4-A647 is reduced in the presence of drug (lower panel “+EHT”) in 
comparison.  
To quantify the effect of drug inhibition on receptor trafficking kinetic, we performed a 
similar loading assay along with an additional step of pre-incubation of the cells with the 
drug. We set the intensity from non-treated control cells as 100%. Figure 4.8B shows that 
internalization of IL-4Rα is reduced to 31% and IL-2Rγ to 52% compared to controls. Since 
Rac1 and Pak1 serve pleiotropic functions, cells are strongly affected by the respective 
inhibitors EHT and IPA. Specifically, they round up upon drug treatment, presumably due to 
effects on the actin cytoskeleton. Thus, the measured intensities may have a large error. In 
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addition, the most strongly affected cells could not be analyzed. Therefore, these measured 
values represent a conservative estimate of the true reduction in trafficking. From the receptor 
trafficking assay, we conclude that both IL-4Rα and IL-2Rγ are trafficked into the endosome 
independent of ligand via Rac1/Pak1 pathway.  
 
Figure 4.8: Effect of EHT-1864 on internalization of IL-4R subunits. (A) Upper panel: Close arrow 
shows accumulation of ligand in the endosome in the absence of drug. Lower panel: In the presence 
of drug, the ligand is absent in the endosomes due to inhibition of the trafficking machinery. Open 
arrow shows the absence of IL-4-A647 in JAK3-eGFP endosomes.  (B) Receptor internalization is 
partially blocked; IL-4Rα up to 31% and IL-2Rγ up to 52% compare to non-treated cells. Error bar 
indicates SEM. 
Next we checked the effect of inhibition of Rac1/Pak1-mediated endocytosis on signaling 
through either type 2 receptor complexes (IL-4Rα/IL-13Rα1) either at endogenous 
concentrations or following overexpression of both subunits. For endogenous conditions, 
cells were transfected with STAT6, whereas for overexpression, cells were transfected with 
the IL-4Rα/IL-13Rα1/STAT6. Cells were pretreated with inhibitors to exert the effect of 
drug. Cells were then washed out and stimulated with ligand IL-4 in presence and removal 
(denoted by “W”) of inhibitors EHT and IPA [67, 68]. Activity of pSTAT6 was analyzed by 
western blot for both sets of experiment. Results show that for endogenous type 2 receptor 
complex, signaling occurs only in presence of ligand (Figure 4.9A). Furthermore, blocking of 
Rac/Pak pathway also blocked pSTAT6 signaling. This signaling can be restored again after 
removal of drugs and the strength of the restored signal is comparable to pSTAT6 signal in 
non-treated cells. Similar results have been shown for Type 1 receptor complex (Kristina 
Kurgonaite, unpublished data). This concludes that endocytosis is an important step for 
signaling to occur and endocytosis occurs upstream of the signaling. However, for ectopic 
type 2 receptor complex (Figure 4.8B), when both subunits are overexpressed, we observed 
two things. First, in the absence of the ligand, we do see signaling which could be a result of 
stoichiometric interaction of overexpressed receptor. Upon addition of ligand, the signal 
intensity is increased due to activation by the ligand. Second, in the presence of drugs 
EHT/IPA, signaling is only partially blocked.   
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Figure 4.9: Effect of Rac/Pak inhibitors on pSTAT6 signaling. (A) Western blot showing an effect 
on pSTAT6 signaling under endogenous condition. Signaling is absent in absence of IL-4 and is 
activated in presence of IL-4. Signaling is completely inhibited in the presence of inhibitors but it can 
be restored after removal of drugs, which is denoted by “W” (wash out). (B) For ectopic type complex 
signaling is on even in absence of IL-4 but it is much stronger in presence of IL-4. In the presence of 
drug, signaling is reduced but not abolished and upon removal of drug (denoted by “W”), signaling is 
increased.  
4.7 Endosomes maintain signaling 
 
To compare the trafficking rates with the STAT6 phosphorylation kinetics we performed a 
pulse-chase. We used the endogenous type 2 signaling machinery for quantifying STAT6 
phosphorylation. pSTAT6 signaling was determined under two different conditions: In 
continuous presence of ligand and after a pulse exposure of ligand. In first case, cells were 
stimulated with IL-4 at 4°C. Cells were then incubated at 37°C to induce endocytosis in 
presence of IL-4. For the second condition, after incubation at 4°C, cells were washed to 
remove ligand from the extracellular media and cells were incubated at 37°C to induce 
endocytosis in the absence of IL-4. In the second condition, signaling should be mainly 
coming from the endocytosed ligand population. Cells were then lysed after particular time 
intervals and the signal was detected by Western blot for both the conditions. Example image 
shows that pSTAT6 signal increases with time (Figure 4.10). Intensity of the bands were 
analyzed by ImageJ and plotted against time. As shown in the figure 4.11, for both the 
conditions, response curves shows a sigmoid shape (EC50 = 12.6 min). Onset of the response 
is slightly delayed with respect to receptor trafficking. The increase of the response persists 
for more than 30 min, without reaching a plateau. The stability of IL-4R/IL-4 complexes at 
the cell surface has a half-life of about 6.5 min [64]. By this time, 95% of the ligand should 
be dissociated during the course of the experiment (30 min). Thus, the time dependence of 
the signaling response suggests that occupied, activated receptors remain present after 
internalization, presumably in the cortical endosomes, and maintain a long lasting output 
towards a transient stimulus. 
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Figure 4.10: pSTAT6 kinetics. Upper panel shows pSTAT6 signaling is increasing with time. Lower 
panel shows control-GAPDH intensity representing number of cells for each sample.  
 
Figure 4.11: pSTAT6 kinetics. The graph shows intensity of pSTAT6 signal plotted against different 
time point. Red fit represents STAT6 kinetics in continuous presence of ligand whereas black fit shows 
in absence of ligand. Both the conditions shows sigmoid shape curve with delayed onset. Signaling is 
sustained for half an hour without reaching a plateau. N=3, Error bar indicates SEM. 
In summary, I was able to prove that both type 1 and type 2 receptor subunits are 
accumulated in signaling endosome. These endosomes are separate compartment where 
ligand and receptors are constantly trafficked via Rac1/Pak1 pathway. Once the receptors are 
activated in the endosome, it may buffer the pathway against temporal fluctuations in ligand 
concentration on the extracellular sites, thus aiding in maintenance of signaling 
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Chapter 5 
 
 
 
 
 
 
 
Results Part III: Regulation of receptor at the molecular level 
 
Preface 5.1 
 
In the previous chapters, I have established that the cytokine receptor containing endosomes 
lie adjacent to the plasma membrane. In addition, these distinct endosomes utilize the 
Rac1/Pak regulated actin polymerization machinery to replenish receptor populations in 
them. In this chapter, I seek to identify the regulator molecules which couple the receptor 
subunits to the actin machinery to achieve this contentious endocytosis 
So far, the most upstream molecule in the cascade regulating actin machinery in the cytokine 
receptor endocytosis is the small GTPase Rac1. Small GTPases act as molecular switches to 
control many cellular pathways. They are toggled between “on” and “off” state by two 
regulatory molecules. GTPase activating protein (GAPs) promote the hydrolysis of GTP to 
GDP through the intrinsic GTPase activity, in turn switching it in “off” state. Guanine 
exchange factors (GEFs), on the other hand, allow GDP to dissociate, facilitating new GTP 
binding and switching the GTPase to “ON” state [69] (Figure 5.1). Among all the others, the 
Rho families GTPases – Rho, Rac1 and Cdc42 - are of special interest as they are known as 
regulators/modulators of actin cytoskeleton and are already known to be involved in several 
endocytic pathways. Specifically, involvement of the Rho family GTPase Rac1 in the actin 
mediated internalization of IL-2 receptor had previously been shown in the IL-2 context [39]. 
There are more than 60 GEFs identified for Rho GTPases. Among these, Vav proteins are a 
group of GEF proteins known to activate Rac1 [70, 71]. They are well studied in both cellular 
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and structural terms [72]. Vav belongs to diffuse B-cell lymphoma (Dbl) family of Rho-
GEFs. Vav family consist of three isoforms in mammals; Vav1, Vav2 and Vav3. Vav1 is 
expressed exclusively in hematopoietic system whereas Vav2 and Vav3 show a broader 
expression. Vav proteins are a multi-domain protein and all mammalian Vav proteins have 
identical domain structures consisting of a Calponin homology (CH) domain – actin binding 
domain, an acidic (AC) domain, the Dbl (DH) domain that contains the Rho-GEF activity, a 
Plekstrin-homology (PH) domain which interacts with polyphosphoinositides, zinc finger 
(ZF) domain, proline rich (PR) rich region and two Src Homology 3 (SH3) and one Src 
Homology 2 (SH2) domain for protein protein interaction.  The N-terminal of Vav is 
involved in its GEF activity whereas the C-terminal is important for interaction with specific 
phospho tyrosine (pY) residues of other proteins. Vav is the only GEF that has DH/PH motif 
in the same protein and SH2 – SH3 domains a characteristic of signal transducer proteins 
[73].  
 
Figure 5.1: Structure of Vav. Vav is a multidomain protein. N-terminus of Vav is important for its 
GEF activity and C-terminus of Vav is important for the interaction with other proteins. Adapted from 
[74]. 
Rho/Rac1 GEFs can be activated in many different ways including plasma membrane 
translocation (Tiam1), migration from nucleus to plasma membrane (Cdc42), interaction with 
G-proteins (Ras GRF, PDZ-RhoGEF) or lipids (Sos,Dbl). In contrast, Vav is activated upon 
phosphorylation [74]. The AC domain of Vav contains three conserved tyrosines (Y) that are 
involved in auto inhibition of Vav GEF activity. In its inactive form, Vav is in a closed 
confirmation by binding of the AC domain in to active site of the DH domain, thus blocking 
GEF activity. Vav GEFs are activated upon phosphorylation of conserved acidic domain 
tyrosines (Y142, Y159, and Y172) that disrupt this autoinhibitory interaction between the 
acidic domain and the GEF catalytic Dbl homology domain [75, 76].  
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Figure 5.2: Structure if inactive and active form of Vav. In an inactive form Vav is in close 
confirmation by blocking the access of phospho -tyrosine residues in acidic domain.  Upon 
phosphorylation of tyrosine residues in AC domain auto inhibitory loop opens which allows access of 
DH domain which promotes GEF activity. Adapted from [74]. 
Vav2 is known to regulate many signaling pathways downstream of receptor activation. 
Apart from the receptors, the upstream elements regulating Vav pathway are protein tyrosine 
kinases and adaptor molecules. Together with EGFR, PDGFR, BCR and TCR, Vav has been 
known to be involved 35 different membrane receptor pathways [77-79]. Also direct 
interaction of Vav with prolactin receptor [80], EPO-R [81], insulin receptor β subunit[82], 
gp130 and CD5 [83]have been reported [84]. For EGF receptors, Vav2 is known to slow 
down the receptor internalization and degradation thereby promoting enhanced signaling 
[85]. Importantly, involvement of Vav2 is also reported for IL-2 mediated signaling [69].  
Moreover, both Rac and Vav knockout phenotype in the hematopoietic system is consistent 
with inhibition of IL-2Rγ associated cytokine receptor signaling [86, 87]. Taken together, the 
link between Vav2 and cytokine receptor appears to be strong. However, the precise role of 
Vav2 and its mechanistic effects in cytokine receptor signaling are unknown. We suspected 
that Vav2 might be modulating the signaling by acting as regulator for endosome formation 
upstream of it. 
To begin with, I wanted to check which isoform of Vav is present in our model system- the 
HEK cell line. Because HEK cells are epithelial cell line, I investigated the presence of only 
Vav2 or Vav3 but not Vav1. Non transfected cells were lysed and analyzed by western blot. 
Figure 5.3 shows that only Vav2 is detectable in HEK293T cell line. So, I proceeded with 
Vav2 for the further experiments. 
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Figure 5.3: Detection of Vav2 and Vav3 in HEK293T cells by western blot. Image shows that Vav2 
is present in HEK293T cells but Vav3 cannot be detected. GAPDH serves as a control.   
 
5.2 Interaction of GEF with endosomes 
 
Next, I wanted to check whether Vav2 localized to endosomes. Expression of non-activated 
Vav2 shows homogeneous distribution throughout the cell. However, we expected activated 
Vav2 to be localized specifically. To verify the association of activated Vav2 with the 
receptors, I performed immunostaining against pVav2, which signifies the active fraction of  
Vav2, in which autoinhibition of the GEF activity is released by phosphorylation of the linker 
domain. Cells were transfected with type 1 receptor complex and were stained against pVav2. 
Figure 5.4 shows association of JAK3-eGFP positive endosome (A) with pVav2 (B). 
 
Figure 5.4: pVav2 association with endosomes. (A) Green channel shows JAK3-eGFP endosomes. 
(B) Red channel shows pVav2 expression in endosomes endosomes and along the periphery. (C) 
Overlay image shows pVAV2 is present in JAK3-eGFP positive endosome, shown by arrow heads. 
Square inset shows close up image of colocalized endosome. Scale bar 10 µm. 
Immunostaining shows association of pVav2 with endosome; however, this does not prove 
that Vav2 is directly interacting with the receptors and associated components. Thus, I used 
biochemical pull down assays to investigate whether there is a direct interaction between 
vav2 and any of the receptor components. Cells were transiently expressed with GFP tagged 
JAK3 and IL-2Rγ alone, as well as JAK3 + IL-2Rγ complex where either of them was tagged 
with GFP. Cells were lysed 24hr post transfection and pull down was performed with GFP 
and was detected with α-Vav2 and α-pVav2 antibody. Western blot shows that JAK3 + IL-
2Rγ complex interacts with Vav2 as well as pVav2 (Figure 5.5). Cytoplasmic JAK3 also 
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interacts with Vav2 and activated pVav2. While IL-2Rγ can bind to Vav2, it fails to pull 
down pVav2. This suggests that Jak3 is required for activation of Vav2 and in the absence of 
JAK3, Vav2 is bound to IL-2Rγ, but is not activated. 
 
Figure 5.5: Interaction of Vav2 and pVav2 with type 1 receptor components via pull down. First 
two lane shows JAK3 and IL-2Rγ interacts with Vav2 and pVav2. Third lane shows cytoplasmic JAK3 
is able to interact with both but IL-2Rγ cannot interacts with pVav2. eGFP serves as a control.  
 
5.3 Domain specific interaction of Vav2 
 
We wanted to further characterize the specific interaction site of Vav2 with JAK3 and IL-
2Rγ. To map this interaction, we created truncated forms of Vav2 with different domains 
deleted. I created two N-terminal domains; (1) N-term, (2) ΔSH2SH3 and three C-terminal 
domains consist of two SH3 domains; (1) SH3a, (2) SH2 domain and (3) SH3b (Figure 5.6).  
To avoid the background detection of interaction of endogenous Vav2 with JAK3 and IL-
2Rγ, domains were tagged with hemagglutinin (HA) tag. For the experiment, cells were 
transiently expressed with N-terminal and C-terminal domains together with JAK3-eGFP+IL-
2Rγ or JAK3+IL-2Rγ-eGFP complexes as well as JAK3-eGFP and IL-2Rγ-eGFP separately. 
GFP pull downs were detected with α-HA antibody to study domain specific interaction. 
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Figure 5.6: Domain specific interaction of Vav2. (A) Structure of Vav2 (B) N-terminal domains of 
Vav2 tagged with HA. “Nterm” consist of CH and AC domain; ΔSH2SH3 consist of CH, AC and DH 
domain. (C) C-terminal domain of Vav2. Three individual domains SH3a, SH2, SH3b tagged with 
HA.Adapted from [74]. 
Figure 5.7A shows that JAK3+IL-2Rγ-eGFP complexes interact with both Nterm and 
ΔSH2SH3 constructs (red rectangle). JAK3-eGFP alone does not interact with the N-terminal 
domains. However, the C-terminal domains-SH3b and SH2 interact with JAK3-eGFP+IL-
2Rγ/JAK3+IL-2Rγ-eGFP as well as JAK3 alone (Figure 5.7B). Presumably, interaction of 
SH2 and SH3b to JAK3+IL-2Rγ is due to a binding of the Vav domains with JAK3. 
However, SH3a doesn‟t interact with either of them. Thus, I conclude that Vav2 is interacting 
with IL-2Rγ with its N-terminal part and with JAK3 via its C-terminal part.   
 
         
Figure 5.7: Interaction of N-terminal and C-terminal domains of Vav2. (A) First two lanes show 
that Nterm and ΔSH2SH3 interacts with JAK3+IL-2Rγ complex. Bands are marked by red 
rectangular.  Last two lanes show JAK3 doesn’t interacts with N-terminal domains. (B) Domain SH3a 
doesn’t interact with JAK3+IL-2Rγ complex or JAK3 alone. SH2 and SH3b interact with both the 
complex and JAK3 alone. This pull down shows that C-terminal of Vav2 is interacting with JAK3+IL-
2Rγ via JAK3 binding.   
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5.4 The IL-2Rγ cytoplasmic region is important for the endosome formation 
 
We mapped the interaction site of JAK3 and IL-2Rγ on Vav2. In a similar way, I wanted to 
check which region of IL-2Rγ is important for endosome formation. To check this, we 
created a truncated version of cytoplasmic tail of receptor (Figure 5.8). IL-2Rγ cytoplasmic 
region was truncated from Δ80 to Δ25 amino acid lengths. This means in Δ80, there are only 
80 amino acid after trans-membrane domain; in Δ70, there are only 70 amino acids after trans 
membrane domain and so on.  
 
Figure 5.8: Schematic representation of truncated mutants of IL-2Rγ. Figure shows N-terminal 
extra cellular domain, transmembrane domain and cytoplasmic tail region of IL-2Rγ. The names 
depict that proceeding from left cytoplasmic tail of IL-2Rγ is truncated after wild type (WT-86 amino 
acids), from 80 amino acids (Δ80) up to 25 amino acids (Δ25).  
Cells were co-expressed with truncated IL-2Rγ and JAK3-TagRFP. Cells were fixed and 
imaged with confocal microscope for endosome formation. Images (Figure 5.9) show that 
from wild type (86aa) till  50, endosome formation could be observed. Endosome formation 
is absent from Δ40 to Δ25. For Δ40 to Δ25 though JAK3 binding is present endosome 
formation is absent. In this experiment, IL-2Rγ was tagged with eGFP on its C-terminal. To 
abate the possibility that GFP tagging could hinder endosome formation, we repeated the 
same experiment where IL-2Rγ was tagged on its N-terminal. The presence of GFP on either 
N-terminus or the C-terminus did not affect the endosome formation. Regardless of the 
position of the GEP tag, we do not observe endosome formation after Δ50-50 amino acids. 
We suspect that this region could be the putative binding site for the Vav2 and thus, results in 
absence of endosome formation.  
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Figure 5.9:  Endosome formation by IL-2Rγ truncated mutants. Left panel shows expression of 
truncated mutants of IL-2Rγ tagged with eGFP on C-terminus (green channel). Middle panel shows 
JAK3-TagRFP expression (red channel) and right panel shows overlay of both the channels. From IL-
2Rγ_Δ80-eGFP to IL-2Rγ_Δ50-eGFP shows endosome formation (white arrow heads) with 
coexpression of JAK3. On expression of IL-2Rγ_Δ50-eGFP ,endosome formation is abolished. From 
IL-2Rγ_Δ40-eGFP to IL-2Rγ_Δ25-eGFP, JAK3 and IL-2Rγ co expression shows only homogenous 
plasma membrane distribution (blue arrow heads) but no endosome formation. Scale bar 10 µm. 
 
5.5 Interaction of Vav2 with IL-2Rγ truncations 
 
To verify if the 50 amino acid region of IL-2Rγ from the transmembrane domain is crucial 
for Vav2 binding, I did a pull down assay with cells transiently expressing VAV2, JAK3 and 
IL-2Rγ truncated mutants tagged with eGFP.  
 
Figure 5.10: Pull down assay of Vav2 with IL-2Rγ truncated mutants. Vav2 shows interaction with 
all the mutants. Interaction is decreasing with decreasing number of amino acids oh the tail region 
except Δ25. Interaction of Vav2 with Δ40 and Δ25 could be due to the indirect interaction with JAK3. 
 
 
55 
 
Vav2 shows interaction with all truncated mutants of IL-2Rγ (Figure 5.10). From WT to Δ50 
Vav2 interaction was expected as they are able to form endosomes. The interaction of Vav2 
with Δ40 and Δ25 could be due to the indirect interaction of Vav2 to IL-2Rγ via JAK3.     
Next, we wanted to check interaction of IL-2Rγ and Vav2 in the absence of JAK3 to avoid 
indirect interaction. Since IL-2Rγ is not recruited to the plasma membrane in the absence of 
JAK3, we directly targeted IL-2Rγ to the membrane (Figure 5.11A) by creating a 
myristoylated version of IL-2Rγ. The extracellular and the trans-membrane domain of IL-2Rγ 
were removed and the molecule was myristoylated before the cytoplasmic region. This 
enables IL-2Rγ to escape the secretory pathway and is targeted directly to the plasma 
membrane. As shown in the image, myristoylated IL-2Rγ (Myr-IL-2Rγ-eGFP) is able to 
translocate to the membrane even in the absence of JAK3 (Figure 5.11B). 
To check if Myr-IL-2Rγ-eGFP is able to recruit JAK3, cells were transiently expressed with 
Myr-IL-2Rγ-eGFP-eGFP and JAK3-TagRFP and imaged by confocal microscope. Figure 5.9 
shows Myr-IL-2Rγ-eGFP is able to recruit to JAK3, but their co expression does not form 
endosomes. 
To force endosome formation with cytokine receptor components, we co-transfected cells 
with Myr-IL-2Rγ-eGFP and wild type IL-2Rγ and JAK3-TagRFP. As shown in the figure 
5.13 expression of JAK3 together with wild type IL-2Rγ is able to form endosomes (a,d).  
Also, Myr-IL-2Rγ-eGFP is recruited to the endosome (b,e). This suggests a putative role of 
transmembrane domain or a cooperative effect with Jak3 in receptor recruitment to the 
plasma membrane.  
 
Figure 5.11: Myr-IL-2Rγ-eGFP expression. (A) IL-2Rγ is alone is localized in perinuclear region. 
(B) Myristoylated IL-2Rγ is recruited to the membrane even in the absence of JAK3. Scale bar 10 µm.  
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Figure 5.12: Myr-IL-2Rγ-eGFP fails to form endosome. (A) Myr-IL-2Rγ-eGFP is recruited to the 
membrane. (B) JAK3 is also recruited to the membrane by IL-2Rγc. (C) Overlay shows that JAK3 and 
IL-2Rγis recruited to the membrane but they fail to form endosomes. Scale bar 10 µm. 
 
Figure 5.13: Myr-IL-2Rγ-eGFP is failed to recruit in to pre-formed endosomes. (a,d)  Red channel 
shows endosome formation by IL-2Rγ and JAK3-TagRFP. (b,e) Myr-IL-2Rγ-eGFP is recruited to the 
preexisting endosomes. (c,f) Overlay image shows that Myr-IL-2Rγ-eGFP is recruited to the plasma 
membrane and colocalize JAK3/IL-2Rγ positive endosome. Scale bar 10 µm. 
5.6 Vav2 can modulate signaling  
 
So far I mapped the interaction sites of Vav2 and showed that may be it indirectly related to 
endosome formation. Next I wanted to check if Vav2 is required for signaling. STAT6 
phosphorylation and STAT6 dependent reporter gene assays provide a highly specific readout 
for IL-4R signaling. To check whether Vav2 has a role in signaling, cells expressing gain of 
function (GOF) and loss of function mutants (LOF) of Vav2 were checked for pSTAT6 
signaling compare to wild type. As reported previously, the first five N-terminal domains of 
Vav1-CADPZ function together to regulate its GEF activity [76]. Based on this study, we 
considered the N-terminal domains with c-terminal parts lacking, as loss of function mutants. 
Also, it has been reported for Vav1 that phosphorylation of Tyr174 is important for its GEF 
activity [71, 76]. However, additional phosphorylation of Tyr142 and Tyr160 facilitate 
activation of Vav1 by making Tyr174 assessable in auto inhibitory loop [88, 89]. 
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Phosphorylation of Tyr142 and Tyr160 makes Tyr174 accessible for the further 
phosphorylation and in turn GEF activation [76]. On the basis of these studies, we performed 
a Tyrosine (Y) to aspartic acid (D) mutation at the amino acid position corresponding to 
similar mutation in Vav1, which holds Vav2 in open active configuration. I made three gain 
of function mutants; GOF1 - Y172D, GOF2 - Y142D + Y159D, GOF3 - Y142D + Y159D + 
Y172D (Figure 5.14).   
 
Figure 5.14:  Schematic of mutation in Vav2 acidic domain (AC). Three Mutations were created at 
three different tyrosine residues in AC domain to make activated form of Vav2. Adpated from [74].  
Cells were co transfected with STAT6 and GOF or LOF mutants of Vav2. Cells were 
stimulated with IL-4 ligand for 30 min and checked for pSTAT6 level. Figure 5.15 shows 
that compared to wild type Vav2, N-term domain constructs show decreased signaling 
whereas  SH2SH3 constructs show increased signaling.  While both GOF2 and GOF3 show 
increased signaling compared to the wild type. Thus, I conclude that Vav2 can modulate the 
pSTAT6 signaling.  
 
Figure 5.15: Effect of gain of function and loss of function of Vav2 on pSTAT6 signaling. The blot 
shows that compared to endogenous pSTAT6 intensity loss of function N-term gives equal signal 
intensity but ΔSH2SH3 gives more signaling. Compared to gain of function (GOF2 and GOF3) the 
signal intensity is less. GOF gives much stronger signal intensity compare to endogenous or LOF 
Vav2. 
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Furthermore I also tried knockdown of Vav2. Cells were first treated with esiRNA Vav2 and 
control RULC esiRNA (Renilla luciferase) and later transfected with STAT6.  Cells were 
lysed after IL-4 ligand incubation and pSTAT6 level was analyzed by western blot. However, 
shows that in presence of esiRNA Vav2, level of endogenous Vav2 is reduced but it does not 
have any effect on pSTAT6 signaling (Figure 5.16). This could be due to the redundancy of 
Vav isoforms.   
 
Figure 5.16: Effect of Vav2 esiRNA on pSTAT6 signaling. In the presence of esiRNA Vav2 is 
diminished but it does not show any effect on pSTAT6 signal compared to control RULC esiRNA. 
GAPDH was used as a control representing number of cells.   
To summarize, I have shown that activated Vav2 is localized endosomes and directly 
interacts with the receptor complex. I have mapped the interaction sites of Vav2 with IL-2Rγ 
and JAK3. I have also shown that the 50 amino acid region of IL-2Rγ is crucial for endosome 
formation. Although we could not establish a direct link between the putative roles of Vav2 
in endosome formation, Vav2 gain of function mutant enhances signaling. We could not see 
any effect upon esiRNA knockdown. This may be a result of redundancy in Vav isoforms. To 
overcome the effects of redundant isoform of Vav, multiple isoform knockouts of Vav are 
required. It is also possible that Vav2 is dispensable and other regulatory proteins function to 
activate the actin machinery resulting in endosome formation and signaling.  
5.7 Outlook  
JAK3 mutant fails to form endosome 
 
An important link between Vav2, signaling and endocytosis is provided by JAK3 mutants 
involved in severe combined immunodeficiency (SCID). A few SCID related mutants of 
JAK3 had been already investigated [57, 90]. Our lab in addition discovered that these SCID 
related JAK3 mutants fail to form endosomes (Figure 5.14 A, unpublished data). Figure 
5.17B shows both JAK3 mutants JAK3-K556A-eGFP (K5) andJAK3-R402H-eGFP (R4) fail 
to form endosomes compare to the wild type. We wanted to check whether Vav2 and pVav2 
interacts with these Jak3 mutants or not. Cells were co-transfected with IL-2Rγ and K5 or R4 
JAK3 constructs. Immunoprecipitation was performed using antibody against eGFP and blots 
probed for Vav2 and pVav2. eGFP was probed as a positive marker. As shown in Figure 
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5.17C, the pseudokinase mutant JAK3-K5 is able to bind Vav and pVav2 (Figure 5.17C). 
However, the R4 mutant, which affects the SH2 domain is able to interact with Vav2 but does 
not selectively pull down pVav2.  
     
Figure 5.17: Co expression and immuno precipitation of JAK3 SCID mutants. (A) Schematic of 
JAK3 kinase, showing mutations in pseudo kinase domain, K5, E6, C7 and in SH2 domain, R4. (B) 
Confocal images of coexpression of IL-2Rγ with wild type as well as JAK3 mutants shows that IL-2Rγ 
forms endosomes upon co expression with wild type JAK3 (a). Co-expression of IL-2Rγ with K5 and 
R4 (b,c) failed to form endosomes. (C) Pull down assay shows K5 mutant is able to interact with Vav2 
and pVav2 while R4 interacts with Vav2 but not with pVav2.  
We presume that R4 is unable to bind pVAV2 because of the mutation in its phospho tyrosine 
binding pocket [91]. This results in impaired stabilization of Vav2 being in open active 
configuration by JAK3. To compensate this, we created a phosphomimic Vav2 gain of 
function mutants, which should not require JAK3 to stabilize it in its active state. Cells were 
transfected with either wild type IL-2Rγ and JAK3 or JAK3-R4, IL-2Rγ and the Vav2 GOF 
constructs. However, while the Vav2-GOF construct affected overall cell morphology, 
formation of the JAK3 positive cortical endosomes was not rescued (Figure 5.18B).  
 
Figure 5.18: JAK3-R402H-eGFP fails to form endosome in the presence of Vav2 gain of function.  
(A) Endosome formation, pointed by red arrow heads upon co expression of JAK3 and IL-2Rγ. (B) co 
expression of R4, IL-2Rγ and Vav2 gain of function do not form any endosomes.         
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Future directions 
      
Although I could show that Vav2 is a suitable candidate as a GEF by showing that Vav2 is 
involved in endosome formation and directly interacts with the receptor, the function of Vav 
as a GEF in cytokine receptor internalization needs further detailed investigations. Our 
experiments, suggests further investigations along the following lines: 
1) Why does Vav loss of function not affect signalling? 
As described before, Vav has three isoforms; Vav1, Vav2 and Vav3. In our experiments we 
could not detect Vav3 by standard western blotting. However, reappraisal of published 
transcriptome data shows that Vav3 is present in HEK293T cells at the level of about 20% of 
Vav2 [92]. Although it is widely assumed that Vav1 is present only in hematopoietic cells, 
we also found that Vav1 is present at 10% of the level of Vav2 in HEK293T cells. Therefore, 
future experiments should involve knocking out all the three isoforms to clearly elucidate the 
function of Vav. There is also a possibility of a different GEF functionally substituting for 
Vav. In addition the knock down efficiency achievable by esiRNA may in principle be 
insufficient, and other approaches such as genetic knockouts may be required. 
2) Why is Vav2 pulled down with truncated mutants of IL-2Rγ? 
A possibility is that Vav2 is connected to JAK3 and IL-2Rγ of different complexes and not 
within the same complex. This might explain the pull down of Vav2 in truncated versions of 
IL-2Rγ. The 40aa of IL-2Rγ may also be important for other protein-protein interactions. 
During preparation of this thesis another paper has been published that implicated Vav2 in 
IL-2R internalization. The signalling factor PI3K is a specific regulator of the clathrin-
independent dynamin-dependent endocytosis of IL-2 receptors [93]. PI3 kinase facilitates 
conversion of PIP2 to PIP3 and induction of Vav2 which activates Rac1. Activated Rac1 is 
recruited to the sites containing IL-2R and enhances the actin polymerization rate. This 
suggests a potential role of PI3 Kinase in endosome formation, that will have to be 
experimentally separated from the contribution of Vav. 
 
. 
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Discussion 
 
During recent years many studies have revealed that synergistic interactions of cell signalling 
processes and endocytosis are important for various cellular processes including e.g. animal 
development, metabolism, motility, differentiation, and immune responses. It is therefore 
well established that signalling and endocytosis processes are functionally and 
mechanistically linked in many receptor systems. This also means that the degree to which 
signalling and endocytic machinery can be independently manipulated in experiments is 
limited and a variety of tools are required to elucidate the relationships between these 
machineries. 
In this thesis, I explored the significance of endosomes for cytokine signalling. Previous 
studies had established that, upon binding of ligands, cytokine receptors oligomerize, which 
brings the associated JAK kinases into close proximity, resulting in activation by cross-
phosphorylation [55]. For certain cytokine receptor pathways it had also been observed that 
the activated receptors localized in endosomes upon activation. However, the details of how 
and why the receptors localize to endosomes were not known. It also remains to be elucidated 
whether endocytosis serves as a termination mechanism or has a positive role in signalling.  
The Weidemann and Bökel labs focused on one cytokine receptor, IL-4R, which forms two 
types of complexes; termed type1 and type2. Type1 IL-4R complexes comprise of the 
receptor subunits IL-4Rα and IL-2Rγ bound by IL-4, whereas type2 complexes comprise of 
the subunits IL-4Rα and IL-13Rα1 bound by either IL-4 or IL-13 [53]. Extensive studies 
have been carried out on the receptor affinity, receptor localization and receptor 
internalization of IL-4R components [94, 95]. However, these studies have not elucidated the 
mechanistic details of pathway activation under physiological conditions.  
Worch et al. showed that neither IL-4Rα nor IL-2Rγ exist as pre-formed dimers at the plasma 
membrane [96]. This suggests that ligand binding must take place to drive the receptors to 
undergo complex formation. Weidemann et al. reported for the first time a systematic 
investigation of the receptor-complex formation at single molecule resolution in live cells 
[47]. Under over-expressed conditions and using FCCS, they reported that ligand could 
induce detectable dimerization in type 2 IL-4 receptor system, but for type 1 IL-4R 
complexes, IL-2Rγ recruitment was not detected. This suggested that the type 1 receptor 
complex formation may be facilitated by a more complex mechanism. This required precise 
measurement of affinities between the receptors. Before I joined the project, complex 
formation between the receptor subunits of the different IL-4R complexes was characterised 
using an improved FCCS approach in living cells (TW, unpublished data). Using this 
approach we observed that respective ligands can indeed induce the formation of all three 
receptor complexes on the plasma membrane albeit with low efficiency. FCCS also allows 
the quantification of the average numbers for individual receptor and complex species within 
the focal volume. From this, dissociation constants for these complexes (Kd2D) can be 
estimated. Since the complex formation and dissociation take place at the plasma membrane 
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the two-dimensional Kd,2D is given in units of receptors/µm
2
.  The Kd2D values we obtained 
were 200 ± 40 receptors/μm
2
 for the IL-4Rα:IL-4/IL-13Rα1 interaction, 530 ± 100 
receptors/μm
2
 for IL-4Rα/IL-13:IL-13Rα1, and 1100 ± 170 receptors/μm
2
 for IL-4Rα:IL- 
4/IL-2Rγ. 
Although these values for affinities are surprisingly low, they do make sense with respect to 
signalling strength of the respective complexes. The dimerization probabilities deduced from 
the Kd values measured by FCCS, follows the order - IL-4/type 2 > IL-13/type 2 > IL-
4/type1. According to the classical view that receptor dimerization is the limiting factor for 
pathway activation, higher affinities should translate into stronger signalling output. In 
agreement with this old hypothesis [97], our affinity data correlates with the signalling 
strength which was determined by the level of pSTAT6 signalling intensity for all three 
receptor complexes (Kristina Kurgonaite, unpublished data). In contrast, in the structural 
study by Laporte et al, the affinities between isolated ectodomains (IL-4:IL-4Rα/IL-13Rα1 
and IL- 4:IL-4Rα/IL-2Rγ) as measured in free solution failed to correlate with the signalling 
strength, thus requiring complex explanations for the relative signalling strength [98]. 
Curiously, physiological cytokine receptor concentrations are about 1 receptor/µm
2
 [99], 
which is at least two orders of magnitude below the measured kd values. Thus, even at full 
ligand occupancy dimerization will be very low at the plasma membrane. In our 
overexpressed condition we worked at plasma membrane receptor density of around 300 to 
500 receptors/μm
2
, which was just about sufficient to detect complex formation. However, 
this observation suggests that a concentration step is required to facilitate receptor 
dimerization. Simultaneously, we observed that the receptor components were localized into 
speckle like structures in the live cells. We suspected these to be endosomes, which 
potentially could actively enrich the population of receptors, allowing overcoming the weak 
affinities and thereby, facilitating complex formation. 
To test this hypothesis, we proceeded with the molecular characterization of the speckle like 
structures. We found that these endosomes are positive for both early recycling Rab markers 
Rab5, Rab11. In addition, I could show that they are also labelled by immunostaining against 
the ESCRT factor Hrs, a marker for multi-vesicular bodies [100]. Consistently, I could show 
by electron microscopy that these endosomes are multi-vesicular bodies of approx. 300nm in 
diameter that are tightly associated with the actin cortex. Quantification of IL-2Rγ/JAK3-
eGFP-gold particles on the plasma membrane and on the limiting membrane of the 
multivesicular endosomes from TEM images have shown that the number of gold particles 
per unit length is enriched approximately 10 fold on the limiting membrane compared to the 
adjacent plasma membrane. Considering that the endosomal limiting membrane is a two 
dimensional surface, we can approximate the ratio of receptor density per area between 
endosomal and plasma membrane surface density from the linear density by squaring. The 
receptor subunit IL-2Rγ is therefore enriched about 100 fold within the endosomal limiting 
membrane. This enrichment takes the local receptor concentration into the range of measured 
Kd values, which is also the range at which receptor dimerization can efficiently take place.   
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To further understand the mechanism of enrichment, we probed the route of trafficking of the 
IL-4 receptors into the endosomes. Previous studies had already established that IL-2Rγ chain 
can be internalized in both constitutive and ligand induced manner [40, 101]. IL-2R chain can 
be internalized, in the IL-2R context by Rac1/Pak1 mediated mechanism [37].  It has been 
also shown for the IL-4 system that the presence of ligand IL-4 induces internalization of IL-
4Rα but they did not specify which pathway [43]. In these experiments, the receptor 
internalization was tracked using radio labelled ligand IL-4 and the surface bound receptors 
were quantified by acid stripping methods over time scales of hours. Instead, we used 
receptors carrying a hexahistidine tag on their N-terminus, which could be specifically 
labelled with fluorescent dyes and can be monitored independent of ligand. Since this 
approach allows live cell imaging, our experiments represent a more accurate measurement 
of the rapid dynamics of receptor trafficking which occurs on a time scale of minutes. We 
observed that IL-4Rα is internalized with similar rate irrespective of the presence of ligand. 
This, to our knowledge, is the first report quantitatively describing constitutive trafficking of 
the IL-4Rα to a defined internal structure.  This is in stark contrast to other pathways like 
TGFβ and RTKs, where receptor uptake is generally shown to be a consequence of pathway 
activation [9]. We also observed that the trafficking kinetics of IL-4Rα and IL-2Rγ are 
similar with a half time around 8 min. These trafficking kinetics explains the slow endosomal 
recovery rate observed by FRAP, and also suggest that all three receptor subunits are 
trafficked to the same target compartment using the same pathway. We prove this 
presumption by using pharmacological inhibition to interfere with a specific endocytosis 
route. It is well established that IL-2R subunits are internalized via Rac/Pak mediated actin 
regulatory pathway [41]. Consistent with this, we observed that type 1 IL-4R subunits IL-4 
and IL-4Rα are also trafficking via Rac1/Pak1 pathway, as receptor and ligand internalization 
was inhibited when this pathway was specifically blocked using drugs. This further leads to 
inhibition of signalling (Kristina Kurgonaite, unpublished data)  
The absolute enrichment we observe from EM is about 100 times and the rate of 
internalization is with a half time of about 8 min. The enriched concentrations in the 
endosomes are a steady state value. To maintain this enriched concentration in the endosomes 
(Cendosome) compared to the concentration at the plasma membrane (Cpm), the rate of 
internalization (kin) must be much faster compared to the rate of trafficking out (kout).  
                       
                  
              
This kind of maintenance of steady state concentration is in contrast to other regulated 
endocytic pathways such as clathrin-mediated endocytosis, where phosphorylation of 
receptors lead to recruitment of ubiquitin ligases, which serves as an internalization signal 
and drives an active internalization, resulting in an increased internalization rate upon 
activation.  As a consequence, e.g. EGF receptors are only transiently localized to the 
endosomes from which they signal. 
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Based on the following observations: 1. The receptors have very low affinity at the plasma 
membrane 2. The receptors are enriched in endosomes. 3. The receptors are trafficked 
constitutively in an actin machinery dependent manner irrespective of the presence of the 
ligand; we propose a new model for the function of endosomes, where the endosomes fulfill a 
thermodynamic role in cytokine signalling. The endosomes act as a site of subcellular 
receptor enrichment, where the dynamics of trafficking are tuned so that it results in an 
increased concentration of the receptors, thereby enabling them to overcome their weak 
affinities and dimerize in the presence of ligand. The observation that this concentration is 
maintained even in the absence of the ligands suggests that the endosomes are poised to 
signal as soon as the ligands are internalized with the receptors.  
To confirm that in accordance with our model, the receptor dimerization indeed takes place in 
endosomes, FLIM/FRET technique was used to detect receptor dimerization within the 
endosome (Christian Bökel, unpublished data). For detecting active receptor complex 
formation, life time shift in donor IL-4Rα CyPet was measured with acceptor IL-2Rγ YPet or 
IL-13Rα1 YPet in the presence of ligand IL-4 at the plasma membrane and within the 
endosome. For low affinity type 1 receptor, we detected pronounced reduction in donor 
lifetime only within the endosome (2.06 ± 0.05 ns vs. 1.57 ± 0.06 ns, p < 0.01) while the 
effect was much less pronounced at the plasma membrane (2.29 ± 0.05 ns vs. 2.18 ± 0.07 ns). 
In contrast, for the higher affinity type 2 receptor complex we observed strong reduced donor 
life time shifts both within the endosome (2.16 ± 0.06 ns vs. 1.78 ± 0.04 ns; p < 0.01) as well 
as at the plasma membrane (2.34 ± 0.04 ns vs. 1.85 ± 0.04 ns, p < 0.01). In agreement with 
the FCCS results, presence of ligand induces some degree of dimerization at the plasma 
membrane. However, it should be noted that this is again an overexpression system. Under 
physiological conditions, when the receptor concentrations are low at the plasma membrane, 
we still expect oligomerization to be happening exclusively within the endosomes.  
We further reasoned that if the endosomes only serve a thermodynamic purpose of allowing 
complex formation by enriching the receptor densities, their necessity could be by-passed by 
expressing high enough concentration of receptors on the plasma membrane. Active 
signalling from the plasma membrane can be inferred by probing pSTAT6 in the presence of 
Rac/Pak inhibitors EHT and IPA. When only one of the receptors is over expressed, no 
signalling takes place, indicating insufficient dimerization even in the presence of ligand 
occupied receptors. However, when both the receptors are overexpressed, signalling is 
restored even when endosome formation is blocked, confirming our hypothesis that the 
primary reason behind absence of signalling from the plasma membrane is the insufficient 
concentration of receptors. Under physiological conditions, the endosomes provide a means 
to overcome this low concentration by enriching the receptor subunits in a confined 
compartment.  
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Figure 6.1: Schematic model of type 1 IL-4R trafficking and signaling. IL-4R subunits IL-4Rα 
(orange) and IL-2Rγ (green) do not form active receptor complex on the plasma membrane due to low 
affinity between receptor subunits. Receptor subunits are constitutively internalized independent of 
ligand IL-4 (red) from the plasma membrane into the endosome that are stably anchored within actin 
cortex (magenta lines) via Rac/Pak pathway. This leads to the high concentration of receptors within 
the endosome. Endosome facilitates to overcome weak affinity and receptor forms active complex 
within endosome.  
Signalling from endosomes where high steady state concentration is maintained by low exit 
rates may also provide other advantages. For example, dependent on the dynamics of 
trafficking, the signalling can be buffered against extracellular fluctuations in ligand 
concentration through sustained signalling. We showed this by assaying the pSTAT6 kinetics 
after pulse chase exposure of ligand. We observed that the signalling still increased 30 
minutes after ligand removal, although, according to the published half-life of the ligand 
receptor complex ≈7min [64]. If the active receptors remained at the membrane, by this time 
95% of ligand should have dissociated into the external milieu. Presumably colocalization in 
to the small internal volume of the endosomes allows efficient re-binding of ligand to the 
receptor.  
According to our model, endosomes therefore fulfil a thermodynamic function for IL-4R 
signalling. However, it could be that endocytosis is not the only mechanism for receptor 
concentration and activation in the cells. In different cell types or for different cytokine 
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receptor systems, different mechanisms of enrichment might take place. It has been reported 
that for IL-7R, which also shares IL-2Rγ, the receptors are enriched in „raft‟ like membrane 
domains, which may itself provide a required concentration step [44]. On the other hand, 
localization and concentration of receptors in raft may be a prerequisite step for 
internalization, as shown for the IL-2R where clustering of the different IL-2R subunits α-γ in 
rafts is followed by receptor internalization [39].  
It is evident that the IL-4R internalization and actin dynamics are intimately connected. 
However, a tight regulation of the actin meshwork is critical for various modes of uptake. 
While I have shown that the Rac/Pak pathway functionally links the actin machinery to IL-4 
receptor endosomal trafficking, the molecular details of the regulation and evidence of a 
direct coupling molecule were still missing. Rac1 is a member of the small GTPase family of 
regulatory molecules, whose activity state is typically controlled by guanine nucleotide 
exchange factors (GEFs). In our system we suspected this GEF to be Vav2, as Vav GEFs are 
known to modulate actin machineries in many other pathways [70, 73, 75, 85, 87, 102]. In 
addition, the Rac and Vav knockout phenotypes are consistent with a loss of IL-2Rγ mediated 
cytokine receptor signalling [87]. I tested this hypothesis by showing that Vav2 is localized in 
IL-2Rγ and JAK3 positive endosomes. Furthermore, using pull down assays, I showed that 
Vav2 interacts with both the receptor subunit IL-2Rγ and the associated kinase JAK3. 
Importantly, 50 aa of receptor tail are crucial because deleting this region results in inhibition 
of endosome formation. Interestingly, unlike wild type JAK3, mutation of tyrosine binding 
pocket of the JAK3-SH2 domain prevents the internalization of mutant JAK3/IL-2Rγ 
complexes.  Mutant Jak3 protein does not pull down pVav2 and exhibits inhibited endosome 
formation, showing a direct correlation between endosome formation and signalling. 
Conversely, constitutively active mutants in Vav2 lead to increased pSTAT6 levels, proving 
that Vav2 can act upstream of signalling. However, loss of function mutants and esiRNA 
mediated knockdown did not show any effect on pSTAT6 signalling. This could be due to 
several different reasons. Firstly, it could be due to the redundancy of Vav isoforms. 
Secondly, activation of the pathway may require only small quantities of GEF, which may 
remain even after knockdown. Thirdly, there might be other GEFs controlling this machinery 
that are structurally different but functionally redundant.  
In summary, my work has contributed mechanistic detail to a larger effort by the Weidemann 
and Bökel labs analyzing how cytokine signalling, specifically through IL-4R, works at the 
single molecule to tissue level. I contributed to the ultra-structural characterization of the 
endosomes and quantitative analysis of receptor endocytosis. I have shown how endosomes 
can facilitate sustained signalling that may help with the long range cytokine signalling in the 
human body. Finally, I investigated how endocytosis machinery might be regulated at 
molecular level through one of the commonly employed GEFs. Putting together all the pieces 
of the puzzle, we could show that endocytosis fulfils a positive role in cytokine signalling by 
providing a local enrichment compartment for receptors that allow them to overcome the 
thermodynamic barrier for efficient complex formation. Therefore, endosomes fulfil an 
entirely different role compared to previously known functions from other pathways. Our 
experiments provide renewed support to the old model that receptor dimerization is the 
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limiting step for signal transduction [103]. However, instead of dimerization occurring at the 
plasma membrane as it was previously assumed, for IL-4R it occurs in the endosome. Low 
affinities between subunits resolve how cytokine receptors are kept in an inactive state at the 
plasma membrane. Furthermore, endosomal signalling buffers the pathway against local 
fluctuations in ligand concentration. In addition, concentration of ligands and receptors in a 
signalling endosome allows the cell to integrate weak signals over time. This may be 
particularly relevant to immune cells, as they migrate through the body, where they are 
exposed to highly variable signalling micro-environments. This might explain why cytokine 
signalling is tightly associated with haematopoietic system.   
It will be interesting to know for what range of receptors our newly discovered mechanism of 
endocytosis dependent oligomerization may hold true. The process may for different 
pathways also be tuned by regulating the rate of trafficking into the endosomes and rate of 
degradation, which results in different steady state functional concentrations at the endosome. 
However, this requires further detailed investigations into the mechanisms of endocytosis and 
intracellular trafficking. The extent to which such processes can be tuned effectively may 
even eventually be exploited to have desired effects in terms of treatments for diseases caused 
by misregulation of cytokine receptor signalling. 
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Abbreviations 
 
AC   AaaAcidic domain 
CLEM   
CLIC    
Dbl   
DH   
EEA1   
EGF   
EGFR   
ESCRT    
ESCRT-1   
esiRNA   
FCCS   
FRAP  
GEEC    
GEF    
GFP   
GOF    
GPCRs    
HA    
HEK    
Hrs  
  
IL-13Rα1   
IL-2Rγ   
IL-4   
IL-4Rα     
IRS  
ic do i  
Correlative Electron Microscopy 
Clathrin independent carriers 
Diffuse B-cell lymphoma 
Dbl  domain 
Early Endosome Antigen 1 
Epidermal growth factor 
Epidermal growth factor receptor 
Endosomal Sorting Complex Required for Transport 
Endosomal Sorting Complex Required for Transport-1 
Endoribonuclease-prepared siRNAs 
Fluorescence Cross Correlation Spectroscopy 
Fluorescence Recovery After Photobleaching 
GPI-AP-enriched early endosomal compartments 
Guanine nucleotide exchange factor 
Green Fluorescence Protein 
Gain of function 
G protein coupled receptors 
Hemagglutinin 
Human embryonic kidney 
Hepatocyte-growth-factor-regulated tyrosine kinase 
substrate 
Interleukin 13 receptor alpha chain 
Interleukin 2 receptor gamma chain 
Interleukin 4 
Interleukin 4 receptor alpha chain 
Insulin receptor substrate 
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JAK3  
MVB  
NGF    
N-WASP   
Pak1   
PDGER   
PH   
PI3-kinase   
PRR    
Rac1    
ROI    
RTKs    
SARA    
SH2    
SH3    
STAT   
TCR   
TEM    
TGF-β  
XSCID    
ZF   
 
 
 
 
 
 
 
 
Janus kinase 3 
Multivesicular bodies 
Nerve Growth Factors 
Neural Wiskott–Aldrich Syndrome Protein 
p-21 activated kinase 1 
Platelet derived growth factor receptor 
Plekstrin-homology domain 
Phosphatidylinositol 3-kinase 
Proline rich region  
Ras-related C3 botulinum toxin substrate 
Region of interest 
Receptor tyrosine kinases 
Smad anchor for receptor activation 
Src Homology 2 
Src Homology 3 
Signal transducer and activator 
T-cell receptor 
Transmission Electron Microscopy  
Transforming growth factor beta 
X-linked severe combined immunodeficiency 
Zinc finger domain 
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